Synthesis and error correction methods in gene fabrication by Park, Jason (Jason Sun-Hyung)
Synthesis and Error Correction Methods in Gene Fabrication
by
Jason Sun-hyung Park
Submitted to the Biological Engineering Division
in Partial Fulfillment of the Requirements for the Degree of
Master of Engineering
MASSACHUSETTS INSTITUTE.
OFTECHNQLOGY
[NOV 152006 J
.LIBRARIES
at the
Massachusetts Institute of Technology
May 2006
r' ... ...,L :s \J1\.(.., l' e~ o'-e J
© 2006 Massachusetts Institute of Technology
All rights reserved.
Signature of Author: __e:...---.,~~ =--_----.; _
\
Biological Engineering Division
May 25,2006
.11 I A
Certified by:: ------JrF-=~+__---+.-.e.--_
"t'=>< \ "y_ Joseph Jacobson
.Associate Professor of Media Arts and Sciences and Mechanical Engineering
........-. .- '.~._ Thesis Supervisor
Certified by: --......,.70'?'~",..-r=....~--7"5I",e..z_---------------­
v 7 Bevin P. Engelward
Associate Professor of Biological Engineering
Thesis Reader in Biological Engineering
Accepted by: -IJ
I Q. v Ioannis YannasProfessor of Polymer Science & Engineeringair, Biological Engineering Graduate Program Committee
Synthesis and Error Correction Methods in Gene Fabrication
by
Jason Sun-hyung Park
Submitted to the Biological Engineering Division
on May 25,2006 in Partial Fulfillment of the
Requirements for the Degree of Master of Engineering in
Biological Engineering as Recommended by the Biological Engineering Division
ABSTRACT
Gene Fabrication technology involves the development and optimization of
methods relevant to the in vitro synthesis of any given target gene sequence(s) in the
absence of template. The driving purpose of this field of research is to bring about the
capability for on-demand fabrication of a DNA construct of arbitrary length and sequence
quickly, efficiently, and cost-effectively.
The first part of this document describes many of the important considerations in
performing successful de novo gene synthesis from a survey of the literature as well as
from our ow'n work. Recommendations are made for a universally effective, robust, and
simple protocol for potential users of gene synthesis, discussing important factors such as
choice of protocol, source of commercial oligonucleotides, and polymerase choice.
The second part of this document focuses on error correction. Reducing error
rates is one of the main challenges in gene fabrication because high error rates preclude
the possibility of fabricating long gene targets in a practical and economical manner.
Improvements in error rates are essential for continued progress in the development of
gene fabrication technology. I discuss the importance of error rate in gene synthesis from
a practical standpoint and show results in the development of novel methods for the
removal of errors from a pool of synthesized DNA.
Thesis Supervisor: Joseph Jacobson
Title: Associate Professor of Media Arts and Sciences and Mechanical Engineering
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Introduction
Background I Motivation
Gene fabrication involves the development and optimization of methods relevant to the in
vitro synthesis of any given target gene sequence(s) in the absence of template. The driving
purpose of this field of research is to bring about the capability for on-demand fabrication of a
DNA construct of arbitrary length and sequence quickly, efficiently, and cost-effectively.
Current gene synthesis technology is effective for making single genes, but can be slow and
costly, especially for long sequences of DNA or when multiple genes are desired. Through
developments in gene fabrication technology, we hope to remove these boundaries and provide
an invaluable tool in biological and biomedical research and engineering.
The isolation and manipulation of genes and other large DNA molecules is crucial to
many areas of Inolecular biology research. While powerful techniques in traditional molecular
biology have b~~en developed over the years for all sorts of DNA manipulations, the time and
labor expended on such work is substantial. An alternative would be to directly synthesize
desired genes, but synthetic genes are expensive with typical costs (commercially ordered) of $1
to $2 per base (ie. $1000-$2000 for a 1 kb gene) and tum-around times of 2-4 weeks.
Inexpensive, reliable, and fast gene snthesis would greatly increase the number and types of
experiments which could be carried out in such areas as the study of gene pathways and de novo
protein design, and facilitate the construction of large gene libraries at reasonable cost.
There are many uses for synthetic DNA, especially with the continued growth of DNA
sequence and protein structure databases available online. For example, the ability to directly
synthesize a gene and several variants can often be useful in the study of a gene in biological
research, especially with codon optimization for expression in bacterial or other systems. Also,
synthesizing a gene de novo eliminates the need to obtain an organism from its natural habitat in
order to study one of its genes. Gene fabrication technology also allows for the synthesis of
genes with novel functionalities that do not even exist in nature. The ability to synthesize
multiple genes at once also gives researchers the ability to engineer and analyze complete
biochemical pathways, genetic networks, and entire genomes.
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One can imagine that with the continued development and optimization of gene synthesis
technology, ordering synthesized genes will one day be as quick and affordable as ordering
single-stranded DNA oligonucleotides today. When one wants to obtain an oligonucleotide
today, the process is as simple as filling out an order form, waiting a couple days, and paying
$10-$20. While this was not true as recently as 5-10 years ago, costs have come down
dramatically for oligo synthesis through new developments. Once gene synthesis technology
reaches the maturity that oligonucleotide synthesis technology has achieved, many basic DNA
manipulations now performed in the laboratory (for example mutagenesis, cloning, purifications)
could be replaced by simply ordering the exact DNA species desired.
The goals for gene fabrication technology do not stop at the single-gene level, however.
Whereas even robust single-gene synthesis would be an enabling technology for many research
applications, the ability to synthesize large sets of genes at minimal cost would enable certain
fields of research that are currently prohibitively expensive. These include studying interactions
between every member of a particular functional class (Newman et ai, 2003), synthesizing many
mutants of a single gene (for example, alanine scanning mutagenesis (Cunningham et aI, 1989)),
protein design, or labeling all the genes from a single genome with an antigenic peptide tag or
fluorescent protein (Ehrhardt, 2003) for detection.
New kinds of research and design projects will become possible with the development of
improved gene synthesis technology. In the field of Synthetic Biology, researchers are
developing increasingly large and more complex artificial genetic systems, built mostly from
modified genes found in nature (Elowitz et aI, 2000; Basu et ai, 2005; Levskaya et ai, 2005;
Voigt et ai, 2005). Notable examples of completely non-biological DNA designs are beginning
to emerge as well (Shih et ai, 2004; Park et al 2006). The DNA constructs required for some
proposed projects are so large that conventional gene synthesis becomes prohibitively expensive.
These include complex in vitro genetics systems such as that proposed by Church and colleagues
(Tian et aI2004). Other groups are pursuing the direct synthesis of entire simple genomes (Smith
et ai, 2003). Such projects aim both to test hypotheses on the fundamental requirements for life,
and to generate organisms that have been dramatically re-engineered for new purposes, such as
\\'aste processing, energy production, and complex syntheses ofuseful compounds.
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Figure 1 Principle steps in the construction of synthetic genes employing MutS for error-reduction.
The pie chart indicates the approximate amount of time consumed by each step (in hours). with a red
arrow indicating the order of operations. The most time-consuming steps in this process are often
oligonucleotide synthesis and DNA sequencing (including plasmid production). The 24+ and 48+ hours
indicated for each of these represent lower bounds on these processes. possible if performed with
immediate access to the appropriate equipment. If these steps are performed by outside providers. 3-5
days are typical of each step. Box 1:gene segments are synthesized and amplified using conventional PCR
protocols. The resulting products are dissociated and re-annealed so that errors are present as
DNAheteroduplexes (mismatches). Box 2: MutS protein is mixed with this pool of molecules and binds to
mismatches. The error-enriched (MutS-bound) fraction is resolved from the error-depleted fraction by
electrophoresis. Box 3: The error-depleted segments are assembled into the desired gene and amplified by
PCR prior to cloning. (From Carr et al. 2004)
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Gene Synthesis Methods
While commercial sources of synthetic DNA are widely available and becoming
increasingly affordable (Carlson, 2003), researchers may benefit from the ability to make one's
own DNA targets, if they can do so without too much experience or effort.
The first technique for designing synthetic genes in the laboratory was published over 35
years ago (Khorana, 1968). Since then, many variations of protocols on gene synthesis have
arisen in the literature. However, there has been relatively little work comparing variables and
protocols in gene synthesis methods. Some of the parameters that vary most often between
protocols have been the source of oligonucleotides, the method used to parse the gene targets,
choice of ligast~ and/or polymerase-based approaches, assembly protocol, and more. We set out
to address the need to give potential users of gene synthesis a clear picture and set of
recommendations regarding the most important factors to optimize and address in doing robust
and high-quality (low error rate) gene synthesis, combining an analysis of the gene synthesis
literature and ernpirical measurements.
Recent Landmarks in Gene Synthesis and the Need for Error Reduction
There have been a number of recent landmarks in gene synthesis from a number of
separate teams led by Venter, Cello, Church, and Santi (Smith et aI, 2003; Cello et aI, 2002; Tian
et aI, 2004; Kodumal et al; 2004). These groups have demonstrated the ability to synthesize large
molecules of DNA from oligos, with products 5.4, 7.5, 15 and 32 kb in length, respectively. It is
notable that error reduction was of critical importance to each of these groups' accomplishments.
Both the Venter and Church teams found it necessary to purify their oligonucleotides prior to
assembly. The Venter team used a gel-based size separation prior to ligation while the Church
team used a series of selective hybridization selections with selection oligonucletides (Smith et
aI, 2003; Tian et aI, 2004). In one of the reports, the target was a bacteriophage genome and
natural selection reminiscent of work by Stemmer et al in 1995 allowed for automatic selection
of functional clones (though silent mutations could not be detected by the functional assay).
While natural selection is a useful tool, the technique was not generalizable as most gene targets
are not selective. In the other reports, an interrmediate step of cloning and sequencing of
intermediate segments was necessary to get correct full length product.
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Significance of Error Rate and Error Rate Reduction for Gene Fabrication
Error Correction: Theory and Consequences
The theory behind error correction in gene fabrication lies at the intersection of computer
science and biology: error-correcting codes. The central idea behind error-correcting codes is
that multiple noisy or unreliable inputs can be combined to give high-fidelity output. In
"consensus voting," copies of a signal are compared against one another and the consensus is
chosen as the output. In this way, each input signal "votes" on the output signal.
Von Neumann formulated the requirements to simulate a given number of perfect inputs
(Winograd and Cohen, 1967): "A circuit containing N (error-free) gates can be simulated with
probability of error at most f;using N log (N/E) faulty gates, which fail with probability p, so long
as p < Pth." The key feature here is the logarithmic relationship. In terms of gene fabrication, in
order to improve the reliability of the system by a factor of x, the number of DNA molecules
required for error correction scales by only log x.
Figure 2 Example of a circuit
employing error correcting codes
Multiple noisy signals Xi are routed to
components fi for "consensus voting."
The result proceeds to a second round
of "consensus voting" by similar
components di . (Winograd and Cohen,
1967).
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In either an electronic or a biological setting, one needs a means of detecting errors in
order to apply the principles of error-correcting codes. In nature, biological systems maintain
low error rates in DNA replication by comparing newly synthesized DNA to its original
template. For example, methylation of a strand of DNA at a recognition site marks it as an
original - and presumably error-free - template. In the case of an error, a number of repair
mechanisms are set in motion. The mismatch repair system of many organisms detects an error
where a misincorporated base fails to form a Watson-Crick base pair with the base on its
complementary strand (Modrich, 1991).
The concept of an original, presumably error-free copy of DNA acting as a template for
detection of errors is key component of error correction in vivo. However, gene fabrication,
which is de novo DNA synthesis, is quite different. There is no distinguishable original, perfect
copy of DNA. All DNA molecules produced have a discrete probability of containing fairly
randomly distributed errors in their sequence. The standard of quality also differs between gene
fabrication and natural processes. Biological systems, because of silent mutations, mutations
with insignificant effect, or compensatory mutations, are more fault-tolerant than gene
fabrication processes. In contrast, a perfect copy of DNA must be made from scratch in gene
fabrication. Error filtration, correction, and prevention methods are therefore of critical
importance.
The error rate of a gene fabrication process directly affects its usability to synthesize
.DNA for its various applications. What error rate is required to economically and realistically
make DNA of a given sequence length? In terms of molecular biology, this translates to: "How
many clones must be sequenced to have adequate confidence of obtaining at least one perfect
clone?" The calculation goes as follows: For a per-base error rate of P and a DNA target of
length N, the probability that a given clone contains no errors at any position is (l_p)N. For X
clones sequenced, the confidence (C) of obtaining at least one perfect clone is C = 1_(I_(I_P)N)x.
Conversely, for a. given confidence value, the number of clones one expects to sequence is X =
In(I-S) / In(I-(l-P)N). Figure 3 indicates how much more difficult it is to synthesize, for
example, a 6000mer than a 600mer. At a standard error rate of 1 error in 600 bp (Stemmer et aI,
1995, Withers-Martinez, et aI., 1999, Hoover and Lubkowski, 2002, as well as our own observed
rates) a 600mer can be produced with high confidence and only a few clones sequenced. On the
other hand, without a better error rate, one can see that synthesizing a 6000mer is unrealistic and
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nearly impossible. One way to get around this problem would be two synthesize ten 600mer
pieces and clone and sequence them, and then assemble these together into a 6000mer and clone
and sequence them again. On the other hand, an improvement in error rate to 1 in 6000 would
allow one to generate a DNA target about 6000 bp in length with little trouble.
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Figure 3 Gene fabrication of long targets requires improved error rates
A. The purity (defined as the % error-free clones) of gene synthesis products decreases exponentially with
the length of the product synthesized. Error rates shown are 1 in 600 bp (blue) typical of conventional
gene synthesis approaches, 1in 1400 bp (red), and 1in 10.000 bp (yellow). B. The number of clones that
must be sequenced to obtain at least one that is error-free (95% Confidence Interval. The same three error
rates as in (A) are indicated. (From Carr et al., 2004)
Error correction is also a vital aspect of gene fabrication because it cuts down on
sequencing and cloning. Cloning, preparing samples, and sequencing take up almost two-thirds
of the total process time in gene fabrication. Figure 1 shows the process of gene fabrication as a
time pie chart, illustrating the point that by more accurately synthesizing gene targets, one can
not only cut down on the number of clones necessary to get one perfect copy, but also avoid the
need for any time-consuming additional steps such as site-directed mutagenesis.
In order to employ the concept of error-correcting codes in gene fabrication, one makes
the assumption that errors are far outnumbered by correct DNA. Therefore, with many copies of
DNA, a consensus vote between the DNA strands allows for detennination of the correct
sequence and allows for errors to be found and fixed. To accomplish this, an error correction
system must be able to accomplish error detection, error removal, and error repair. The
overarching functional requirements in the development of error correction protocols are: a)
utilization of a molecule with affinity for errors, b) a method for removal of the errors which are
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bound by aforementioned molecules, and c) a process that can be cycled for improvement of
error rate by multiple rounds of consensus voting. The ideal result is a cheap, robust, and
hopefully machine-automatable procedure with short cycle time that results in large
improvements of error rate.
Recognizing errors with MutS: in vivo vs. in vitro
The error-binding molecule of choice in much of our current and future work in the
development of error correction protocols employs the protein MutS. As part of a common
natural mismatch repair mechanism involving MutL, MutH, and MutS, MutS is a protein with
affinity for binding to DNA duplexes in places where they deviate from Waston-Crick base
palnngs. MutS, which has homologs in many organisms, exhibits different sensitivity to
different types of mismatches (Brown et a1. 2001). The sensitivity and specificity of the
lnismatch binding also varies across species.
Affinity is highest for single base deletions, which we have determined to be the most
prominent error in gene synthesis. The different types of mismatches are: AA, CC, GG, TT, AC,
AG, TC, TG, and the bulges caused by short insertions and deletions. E. coli MutS is known to
have poor affinity for CC mismatches (Brown et aI., 2001). In eukaryotes, multiple MutS
homologs with distinct functions together perform the task of mismatch recognition (Eisen,
1998). MutS proteins from thermophilic bacteria, seem to have affinity for all of the types of
mismatches (Biswas and Hsieh, 1995, Whitehouse et a1. 1997).
Figure 4 details the mechanism of action of MutS, MutL, and MutH. As mentioned
earlier, methylation of one of the strands of DNA identifies it as the original copy. In the
absence of strand methylation, both strands are cut by MutH (Smith and Modrich, 1997). This
feature has been utilized in the literature for the removal of errors from synthesized DNA. The
cleaved, error-containing products are separated from non-error-containing products by size
separation in gel electrophoresis.
In de novo gene fabrication, we do not have the luxury of knowing which DNA strands
are "original" and "correct." Further, because of the nature ofPCR-based gene synthesis, errors
in DNA are copied into the comlementary strands of DNA as well. Thus there is the necessity
for dissociating and reassociating DNA duplexes in order to re-assort DNA strands and create
error heteroduplexes in which errors are matched with their corresponding correct bases. This
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mismatch can then be recognized by a protein such as MutS. For lengths of DNA <10-20 kbp,
this re-assortment can be accomplished by thermal denaturation and re-annealing. For larger
targets, one might utilize proteins such as RecA to effect strand transfer between duplexes.
1\
helicase,
exonuclease
1 DNA polymerase.ligase
Figure 4 The mismatch repair system of E. coli.
A DNA heteroduplex is shown. Arrowheads indicate the 3' end of each strand. The top strand contains a
single error (indicated by bulge). The bottom (template) strand contains a methylated GATC sequence.
MutS protein (a dimer. shown as one unit for simplicity) binds to the site of the mismatch. Mutl and
MutH proteins bind to the MutS-DNA complex, and MutH scans the nearby DNA for a GATC (potentially
looping out intervening sequence, not shown). When MutH finds the site, it nicks the unmethylated
strand. Actions of a helicase and an exonuclease digest part of the top strand, until the error is degraded.
ADNA polymerase and ligase then fill in the gap, resulting in a corrected strand (Modrich 1991).
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One of the main issues with MutS for use in error correction in gene fabrication is
nonspecific binding. Especially with longer DNA constructs, nonspecific binding may be a
problem. Depending on the application, our data shows that MutS can be used effectively to
remove errors from DNA of length about 1000 bp or less. In the synthesis of various gene
products including GFP (-1000 bp) and Thermus aquaticus MutS (-2500 bp), we circumvented
this issue parsed the sequences into chunks of -300 bp, error-correcting these pieces, and then
assembling thelTI into the full gene targets through a PCR-based method. However, a method of
synthesis and error correction that does not require this additional step would be preferable.
There exist a number of other molecules used for binding to DNA mismatches, including
T7 endonuclease I (Babon et aI., 2000), T4 endonuclease VII (Youil, 1996), and CEL I
endonuclease (Oleykowski et aI, 1998). These may serve as ready alternatives to the use of
MutS and its homologs.
Scope of this document
This document focuses on two aspects of gene fabrication: gene synthesis and error
correction. Other issues in Gene Fabrication e.g. automation/parallelization by microfluidics and
use of DNA microarrays as a source of oligonucleotides, while important, are beyond the scope
of this work.
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Methods
General protocols
Listed here are a number of general protocols and reagents used in our work. These are not
specific to Gene Fabrication but are listed here for reference. For information on proprietary
reagents and protocols, please refer to manufacturers' documentation.
Cloning
We use the plasmid vector pDONR221 with the Clonase II (Invitrogen) recombination system
for convenient, low-background cloning of some gene targets, such as GFP.
We also use thf~ T7lac-promoter based pET system (Novagen) of vectors for protein expression.
We use different variants of the vector depending on additional features we may want included
in our protein expression. For example, we could use pET-44 to have a NusTag fused to our
protein of interest for enhanced protein solubility.
Restriction enzymes are obtained from New England Biolabs.
Chemically competent cells are obtained from Invitrogen: some common types we use include
DH5a MAX Efticiency, DH5a Library Efficiency, and BL21(DE3).
Protein expression/purification
As mentioned above, we use isopropyl-beta-D-thiogalactopyranoside (IPTG)-inducible T7lac
systems for protein expression. Our standard procedure for protein expression involves an
overnight culture growth at 37°C and 300pm from a colony pick followed by 1:100 dilution into
fresh LB with antibiotic and re-growth at 37°C and 300pm to mid-log phase (-0.6 OD600). The
culture is induced with 1 mM IPTG and incubated at 37°C and 300rpm for 2 hours before
harvesting the cells in a centrifuge. We use either sonication or BugBuster reagent with
Benzonase nuclease (Novagen) to lyse cells.
We use an AKTApurifier (GE Healthcare) system to automate much of our protein purification
work. We use high-flow columns for affinity, ion exchange, and other types of column protein
purification.
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Commercial polymerases for PCR
We have used the following commercially available polymerases in our work:
Taq (NEB), pfuTurbo (Stratagene), PfuUltra (Stratagene), PfuUltraII (Stratagene), Phusion
(Finnzymes), Pfx50 (Invitrogen), KOD HiFi (Novagen), and BD Advantage 2 (Clontech). We
use the manufacturer-supplied buffers and manufacturer-recommended thermal cycling
parameters for our PCRs.
Agarose gel electrophoresis
1% agarose gel electrophoresis with 0.5 Jlg/mL ethidium bromide or IX SYBR Safe (Molecular
Probes) is used to analyze PCR products. Qiagen Gel Extraction Kits (Qiagen) are used to extract
DNA from agarose gel.
Polyacrylamide gel electrophoresis - protein and DNA gels
Polyacrylamide gel electrophoresis (PAGE) is used to analyze protein and DNA samples. Pre-
cast TBE gradient gels (4%-12%) (Invitrogen) are used for DNA analysis and stained with
SYBR Gold (Molecular Probes). The crush and soak procedure is used to recover DNA samples
from PAGE. Precast Bis-Tris gels (6%) (Invitrogen) are used for protein analysis and stained
with Simply Blue SafeStain (Invitrogen).
Gene synthesis: PeR-based methods
As discussed earlier, there are a variety of methods employed for gene synthesis, each
with their unique advantages and disadvantages. The most prominent among these - and the
protocol that we favor - involves the use of the Polymerase Chain Reaction (PCR) to assemble a
pool of oligonucleotides that together make up the target sequence of interest. We favor the
nomenclature Polymerase Construction and Amplification (PCA) for the process - this was the
term coined by Mullis in the first report to employ a thermocycled polymerase-based method
(Mullis et aI, 1986).
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Sequence parsing
A target DNA sequence for gene fabrication is parsed into a set of overlapping
oligonucleotides (--40-70 bp in length) in computer software. The choice of parsing algorithm
depends on the particular needs of a project.
In the simplest parsing scheme, the target sequence can be divided up into equal chunks
of n base pairs. In more complicated algorithms, the sequence can be parsed in ways so as to
optimize for certain parameters including consistent melting temperature, no hairpin formation,
no self-annealing, no primer-dimerization, codon frequency in host organisms, and more. To
allow an extra degree of freedom in oligonucleotide sequence choice, some software allows gaps
and overlaps b(~tween adjacent oligonucleotides of the same strand. An example of this type of
software, hosted at the NIH, is DNAWorks (http: Jlhdhil.!-.jl}ru.nill:£,--~~_~U.J.;J~B2!i-:.~'~_)
The EGFP and Tma MutS sequences used for the optimization and comparison of One-
Step PCA and Two-Step PCA described in this document were parsed using DNAWorks.
Purchasing oligonucleotides commercially
The parsed oligonucleotides are purchased from a commercial vendor. Choice of vendor
is important, as different vendors provide DNA with different error rates. We have demonstrated
that the errors in a starting oligonucleotide pool can make up a high proportion of the errors
present in its resultant synthesized gene product. We compared oligonucleotides from a number
of vendors including Integrated DNA Technologies (IDT), Sigma, Operon, and MWG Biotech.
The EGFP oligonucleotides used for the optimization and comparison of One-Step PCA
and Two-Step PCA described in this document were purchased commercially from Operon with
no additional purification. The Tma MutS olignonucleotides were purchased commercially from
IDT with no additional purification.
One-Step Gene Synthesis: Polymerase Construction / Assembly (One-Step PCA)
While a number of variations on polymerase-based methods for gene synthesis are in the
literature (Gao et aI, 2003), we favor simple approaches we call One-Step PCA and Two-Step
peA. In the next two protocols, the term "outer amplification oligonucleotides" refers to the first
oligonucleotides (5') of the coding and non-coding strands from each pool.
19
In One-Step PCA, 300 oM of each of the outer amplification oligonucleotides and an
amount of the entire pool of oligonucleotides ranging in concentration between 0-50 oM per
oligo are combined (See Figure 5). dNTPs are added to the reaction to a concentration of 1 JlM
total (250 nM each). Reactions are carried out in polymerase manufacturer-provided IX reaction
buffer(s) with a. manufacturer-recommended amount of polymerase.
Reaction mixtures are thermocycled for 45 cycles of denaturation, annealing, and
extension. Temperatures and times for all steps, as well as those for the initial denaturation and
final extension steps, are those recommended by each polymerase's manufacturer.
Products are analyzed and purified by agarose gel electrophoresis.
We tested a number of important variables in the One-Step PCA protocol to determine its
limitations and compare it with the Two-Step PCA protocol described next.
Two-Step Gene Synthesis: Polymerase Construction / Assembly (Two-Step peA)
Two-Step PCA, our preferred protocol for gene synthesis, consists of an Assembly PCR
followed by an Amplification PCR (See Figure 6).
Assembly PCR reactions (in a total volumes of 20 JlL) are set up with an oligo pool
concentration of about 15 oM (each). dNTPs are added to the reaction to a concentration of 0.8
JlM total (200 oM each). Reactions are carried out in polymerase manufacturer-provided IX
reaction buffer(s) with manufacturer-recommended amounts of polymerase units used in each
reaction. Amplification PCR reactions (in total volumes of 50 JlL) are set up with a 1:20 dilution
of the assembly PCR material, 300 nM of each of the outer amplification oligonucleotides, and
0.8 JlM total dNTP (200 nM each). Again, reactions were carried out in polymerase
manufacturer-provided IX reaction buffer(s) with manufacturer-recommended amounts of
polymerase units used in each reaction.
Both steps of the PCA are carried out for 30 cycles, with initial denaturation, final
extension, denaturation, annealing, and extension steps' cycling parameters as recommended by
each polymerase's manufacturer.
Products are analyzed and purified by agarose gel electrophoresis.
A number of important variables in Two-Step PCA were examined and their impact on
an important readout of quality, error rate, was determined. Two-Step PCA was also compared
side-by-side with One-Step PCA in terms of robustness of assembly.
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Figure 5 One-Step Polymerase Construction / Assembly (PCA)
In One-Step PCA, a pool of construction oligonucleotides and a much higher concentration of the
outermost (5' end) oligos of the coding and non-coding strands are combined in a Polymerase Chain
Reaction. Reaction mixtures are thermocycled for 45 cycles of denaturation, annealing, and extension.
The product is a mixture of full-length gene target and shorter incomplete products and side-products.
Thermocycling parameters used are those recommended by each polymerase's manufacturer.
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In One-Step PCA, a pool of construction oligonucleotides and a much higher concentration of the
outermost (5' end) oligos ofthe coding and non-coding strands are combined in a Polymerase Chain
Reaction. Reaction mixtures are thermocycled for 45 cycles of denaturation, annealing, and extension.
The product is a mixture offull-Iength gene target and shorter incomplete products and side-products.
Thermocyc1ing parameters used are those recommended by each polymerase's manufacturer.
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Assays to determine the error rate in a synthesized DNA construct
As discussed earlier, one of the primary measures of quality and a limiting factor in gene
synthesis is the rate at which errors occur in the synthetic DNA. Therefore, it is of paramount
importance to optimize gene synthesis and error reduction protocols to yield error rates that are
as low as possible. This implies the need for quick, accurate, and economical assays for error
rate. Below are the assays we employ most frequently in our work.
Colony Count: Green Fluorescent Protein (GFP) in E. coli
By using Enhanced Green Fluorescent Protein (EGFP) (pEGFP, BD Biosciences) as the
desired target for gene synthesis, one can roughly assay the error rate of a given gene fabrication
process by assessing the percentage of colonies on a plate of selective agar-containing media that
are glowing green under UV illumination.
Full-length EGFP gene constructs are synthesized as described earlier and inserted into
the pDONR 221 plasmid using the BP Clonase II recombination reaction (Invitrogen), with
overnight incubation for maximum transformation efficiency. Competent DH5alpha cells
(Invitrogen) are transformed with these reaction products and cells are plated with kanamycin
selection on LB agar plates and incubated at 37°C. Colonies are grown to maturity in 16-18 h.
The plates are imaged on a Fluorchem8900 gel documentation system (Alpha Innotech) under
UV illumination (365 nm) with a SYBR Green filter. Adobe Photoshop is used for image
enhancement (gamma setting -3, whitelblack threshold adjusted for optimal contrast, false color
green).
From a green/white colony count, one can calculate an approximate error rate per base
pair using the following equation:
(average % silent mutationsr1 * (% green) = (I-error rate per bp)DNA length
1 - «average % silent mutations)-l * (% green))l/(DNA length) = error rate per bp
Note that we can do a similar assay and calculation synthesizing the LacZ-alpha gene and doing
a blue/white screen.
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Flow cytometry ofE. coli expressing Green Fluorescent Protein from synthesized DNA
This assay can roughly be thought of as a scaling up of the GFP colony count to analyze
thousands of single E. coli cells in a flow cytometer instead of single colonies on a plate.
After transformation as described in the Colony Count procedure, the mixture of
transformed cells are diluted in 5 mL LB with 15 flg/mL kanamycin and grown at 37°C in a 300
r.p.m. shaking incubator (Lab-Line). Cultures are grown -18-20 hours and diluted 400-fold into
LB just prior to analysis. Cultures are analyzed using either a FACScan or FACSCalibur system
(BD Biosciences) with a 488nm argon laser in the MIT Center for Cancer Research Flow
Cytometry Core facility. The Low flow setting is used for the FACScan system and the Medium
flow setting is used for the FACSCalibur system. Live cells are differentiated from dead cells
and debris by analysis of the forward and side scattering properties of cells in the sample. The
live cells are analyzed for green fluorescence. The ratio of green fluorescence (530 nm) to yellow
fluorescence (585 nm) is measured so that any cells exhibiting autofluorescence (green:yellow
ratio -1: 1) can be excluded from the green fluorescent cell count. CellQuest Pro (BD
Biosciences) and FlowJo (Tree Star) software are used to analyze flow cytometry data.
Use ofMutS in a gel mobility shift assay
Binding varying amounts ofMutS to a known amount of synthesized DNA and analyzing
by polyacrylamide gel electrophoresis can serve as a rough assay for error rate. The DNA is
thermally denatured and re-annealed before this process. MutS binds more readily to a pool of
DNA that contains many errors than to error-free DNA. This effect can be observed by staining
the gel for DNl\, i.e. with SYBR Gold Stain (Molecular Probes). MutS-bound DNA migrates
through the gel slower than unbound DNA.
This process is also used to purify error-depleted DNA from error-containing DNA.
Refer to the "Gel-based error-filtration via MutS-binding" protocol in the next section for more
information.
Sequencing
Sequencing is the gold standard for error rate determination. The downside of this tool
though, is that it: is costly both in terms of time as well as money. This limits the sample size of
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data sets collected - whereas we can easily collect tens of thousands ofdata points for a set using
flow cytometry, we can only realistically send off tens to hundreds of clones for sequencing.
Regardless, sequencing gives us information that is simply not available using any of the
other techniques. We can precisely count what types of errors exist in our synthesized DNA and
we can note their location on the DNA strand. Also, GFP flow cytometry and colony counts do
not take into account silent mutations or mismatch mutations that only change the intensity of
fluorescence.
We use MIT Biopolymers and Genaissance Pharmaceuticals for sequencing. Both accept
96-well plates - Genaissance only accepts 96-well plates. Samples are provided to MIT
Biopolymers at appropriate concentrations / volumes with primers premixed. Genaissance
accepts bacterial glycerol stocks (10% glycerol in selective LB media) (> 10 JlL) shipped
overnight on dry ice, from which they produce material for sequencing using a TempliPhi
reaction (GE Healthcare). Sequencing primers are sent for the entire plate in 1.5 mL tubes or in
96-well plate format.
One sequencing reaction is performed per sample per -500bp in length using appropriate
primers (internal to the target sequence, sequences in the vector flanking the insert, etc as
necessary). Errors in the sequenced products are analyzed by sequence alignment using
VectorNTI Advance 10: AlignX (Invitrogen) and verified by direct visual examination of
e1ectropherogram output files with Chromas Lite (Technylesium).
Error Removal methods
Reassorting errors into heteroduplexes
As discussed in the Introduction, DNA duplexes in a pool of DNA duplexes in a pool of
synthesized DNA need to be dissociated and reassociated after mixing in order to assort DNA
strands to create~ error heteroduplexes where errors are matched with their corresponding correct
bases. For lengths of DNA <10-20 kbp, this re-assortment can be accomplished by thermal
denaturation and re-annealing. (For larger targets, one might utilize proteins such as RecA to
effect strand transfer between duplexes). In our experience, heating the DNA mixture in a
thermocycler to 95°C for 2 minutes and then gradually ramping down the temperature to room
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temperature over the course of 20-30 minutes has been sufficient for strand reassortment. The
presence of salt is important to prevent DNA backbone repulsion during this process.
We hav(~ observed that this relatively fast anneal protocol seems to create higher-order
structures, some of which are presumably similar in structure to Holliday junctions in
recombination. This is evidenced by high-molecular mass aggregates of DNA that do not migrate
,veIl through non-denaturing TBE polyacrylamide gel electrophoresis. These aggregates
disappear in denaturing TBE polyacrylamide gel electrophoresis. In addition, we have observed
that application of a Holliday junction resolvase such as Thermus T7 Endonuclease I (NEB)
causes the DNA to migrate in gel electrophoresis as normal DNA duplexes of the expected
length.
Gel-based error-filtration via MutS-binding
Newly synthesized DNA product is thermally denatured and re-annealed to re-assort
t~rrors as described above. The DNA is then bound to recombinant MutS by incubation at 60°C
for 10 minutes in a binding buffer (50 mM NaCI, 10 mM Tris pH 8, and 8 mM MgCb).
The mixture is then analyzed by TBE polyacrylamide gel electrophoresis (PAGE) and the
gel is stained for DNA by SYBR Gold (Molecular Probes). Error-containing DNA is bound by
MutS, which shifts its mobility in the gel. DNA that is not shifted In mobility is error-depleted.
This error-depleted DNA is cut out and extracted from the gel by the crush and soak method at
37°C in an elution buffer (10 mM Tris pH 7.5,1 mM EDTA, 50 mM NaCI). This minute amount
of DNA can be amplified by PCR. The procedure can be repeated or the DNA can be used for
cloning.
The precise ratio of MutS to DNA used is important: too much MutS causes nonspecific
binding to dominate and there is effectively no error-free DNA not bound by the MutS, while too
little MutS does not bind enough error-containing DNA to make a substantial improvement in
error rate.
The optimal MutS:DNA molar ratio varies depending on the origin of the MutS (what
species), the length of the DNA, and the error rate of the DNA. However, as a starting point, we
note that the optimal ratio for Thermus aquaticus (Taq) MutS seems to be about 275: 1 (MutS
tnonomer to double-stranded DNA). This corresponds to a 40: 1 mass ratio for a 1000bp DNA
construct.
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Removal oferror-containing DNA via immobilized MutS
In order to improve the cycle time and ease of implementation of error-filtration using
MutS, we worked to extend our results in MutS-mediated gel-based error-filtration by
developing a protocol to perform error-filtration with MutS immobilized to solid supports. We
made use of the His tags we put on our proteins (originally for protein purification) to bind the
MutS to Ni-NTA resins (Pierce) and Ni-IDA HisMag magnetic agarose beads (Novagen).
In this protocol, we bind an excess of our His-tagged MutS to the resin or magnetic beads
and incubate at room temperature for several minutes. After two successive washes in binding
buffer (50 mM NaCI, 10 mM Tris pH 8, and 8 mM MgCh) (sediment by centrifugation or
applying magnet), the synthesized DNA - melted and re-annealed to re-assort errors as described
earlier - is added. After incubation at room temperature for 30 minutes, the MutS-solid support
complex is sedilnented and the supernatant (error-depleted DNA) is set aside for analysis. The
DNA can be roughly quantitated by taking an Abs220nm spectrophotometer reading or running on
a polyacrylamide gel and staining with SYBR Gold stain (Molecular Probes). The material can
also be amplified by PCR and the procedure can be repeated. Sequencing, GFP colony count, or
flow cytometry (in the case of GFP construct) can be used to determine the error rate of the
DNA.
Synthesis and expression ofseveral variants ofMutS
Using the methods discussed in this document, we have synthesized and expressed
variants of MutS from the following organisms: Escherichia coli (Eco), Thermus aquaticus
(Taq), Thermatoga maritima (Tma), and Aquifex aeolicus (Aae). Because MutS is a relatively
large protein (-100 kDa), we employed MutS-mediated gel-based error-filtration to facilitate the
successful construction / cloning of these genes (first using commercially available Taq MutS
from Epicentre, later using our own recombinant Taq MutS).
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Results
Critical Variables and Considerations in Practical Gene Synthesis
Polymerase-based methods vs. Ligase-based methods
We set out to fill a need in the literature for a comprehensive set of practical
recommendations for users of gene synthesis. We began by surveying the literature and
examining the many different approaches in existence for gene synthesis.
First, we decided on polymerase-based approaches to gene synthesis - in which a pool of
oligos prime off of each other to make progressively longer DNA species until they reach full-
length and are amplified exponentially as in PCR - over ligase-based approaches. In ligation-
based methods, complementary groups of oligos are annealed together and covalently joined by
DNA ligase. One of the disadvantages of ligation-based approaches include the requirement that
oligos be phosphorylated at their 5' ends in order for the ligation reaction to occur.
Phosphorylating oligos during oligo synthesis is expensive, and phosphorylating oligos with
polynucleotide kinase post-synthesis is not difficult but adds an additional biochemical
processing step to the gene synthesis process.
In addition, no gaps or overlaps are allowed in parsing genes for ligase-based approaches.
In polymerase-based methods, gaps and overlaps are allowed because the DNA polymerase can
extend the DNA chain from the end of an oligo according to the complementary DNA strand, but
ligase simply covalently links adjacent DNA molecules. Allowing gaps and overlaps adds a
degree of freedom in software parsing in terms of avoiding "hotspots" for mispriming, adjusting
the melting temperature of an oligo, and more. Also, PCR-based gene synthesis is tolerant of a
good portion of the errors resulting from olignucleotide synthesis in which (capping groups..) -
provided that no errors were introduced into the truncated oligo - whereas incorporation of such
an oligonucleotide by ligation-based gene synthesis could possibly result in an error in the final
product.
We favor the nomenclature Polymerase Construction and Amplification (PCA) for the
aforementioned family of polymerase-based approaches to gene synthesis, after the term coined
by Mullis in the first report to employ a thermocycled polymerase-based method (Mullis et aI,
1986). Variations of this general protocol in the literature include approaches with several
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sequential assembly/amplification reactions (Stemmer et aI, 1995; Smith et aI, 2003) and
methods where the entire gene synthesis process is condensed into a single reaction (Tian et aI,
2004; Wu et aI, 2006). The recommended arrangement and concentration of construction
olignucleotides also varies in the literature. Most of the time, the oligonucleotides are parsed to
arrange themselves linearly (refer to Figure 5 or Figure 6). However, alternatives presented in the
literature include a circular arrangement to generate a concatamer (Stemmer et aI, 1995) and
oligonucleotides arranged to assemble from the center of the construct on out (Gao et aI, 2003).
In terms of concentration, some recommend the same concentration of all olignucleotides in the
pool, some a high concentration of the "outside" primer oligos, and others a gradient.
One-Step PCA vs. Two-Step PCA
Given a straightforward parse and a linear arrangement of construction oligonucleotides,
one needs to make the choice between using one or two steps of PCR in synthesizing the gene
construct. In T~ro-Step PCA, the first PCR is an assembly PCR - all oligos are present at the
same concentration and successively longer gene products are formed as the oligos prime and
extend off one another. The second PCR is an amplification PCR, where a high concentration of
the "outside" primers and a dilution of the assembly PCR are put in the reaction to efficiently
and selectively amplify the full-length gene product of interest. In One-Step PCA, the assembly
and amplification steps are condensed into a single reaction with both a high concentration of
"outside" primers and an otherwise uniform concentration of construction oligos in the pool.
One-Step PCA is presented in (Tian et aI, 2004) and studied further in (Freeland et aI, 2006),
though under different nomenclature in each case.
While One-Step PCA has the advantage of reduced sample handling and somewhat
reduced reaction time, our experience had been that One-Step PCA is very effective for short
gene products «500bp) but that the approach gave less specific product and was less robust than
Two-Step PCA and required more optimization for longer products.
We systematically evaluated One-Step PCA, taking into account four key parameters:
polymerase/buffer choice, length of construct, number of construction oligos in the pool, and
initial concentration of construction oligos in the reaction.
DNAWorks-parsed oligonucleotides derived from GFP "target sequence were separated
into four pools with expected sizes of correctly assembled products from each being 264 bp (12
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oligonucleotides), 475 bp (22 oligonucleotides), 682 bp (32 oligonucleotides), and 993 bp (42
oligonucleotides). A 2406 bp target sequence (Tma MutS gene) was separated into five pools in
a similar manner. The sizes of the correctly assembled products from each of the five pools were
expected to be 545 bp (20 oligonucleotides), 1075 bp (38 oligonucleotides), 1621 bp (56
oligonucleotides), 2163 bp (74 oligonucleotides), and 2406bp (90 oligonucleotides).
The polymerases / buffers used for this experiment were PfuTurbo, BD Advantage 2, and
Phusion. The range of oligo concentrations used was 0-50 nM (each).
Looking at Figure 7 and Figure 8, one can see some trends important in choosing these
key parameters in One-Step PCA. BD Advantage 2 (Clontech) outperforms the other
polymerases in terms of maximum gene length, yielding products as lage as 1621bp (and
possibly 2163bp). However, this polymerase exhibits an unacceptably high error rate and is not
recommended for use in PCA. There is clearly an optimal oligo pool concentration in the vicinity
of 10-20 nM (each). There is length-dependence - longer products with more oligos tend to be
nlore difficult to build by One-Step PCA than shorter products with fewer oligos.
Next, we compared non-optimized Two-Step PCA builds with optimized One-Step PCA
builds. For simplicity and to test sensitivity to construction oligo construction, we left the total
oligo pool concentration of the first assembly PCR at 500 nM total for all reactions. Thus, per-
oligo concentration varied depending on construct, and for the 250 bp assembly each
oligonucleotide was present at 35 nM while for the 2500 bp product each oligo was present at
only 5 nM. Despite this, strong product bands were generated in all Two-Step PCA's. See Figure
9 for a direct comparison of optimized One-Step PCA builds and non-optimized Two-Step PCA
builds for constructs of a variety of lengths with Phusion polymerase.
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Figure 7 One-Step PCAof EGFP fragments with various polymerases at varied oligo pool concentrations.
Target DNA constructs oflength 264 bp (12 oligos), 475 bp (22 oligos), 682 bp (32 oligos), and 993 bp (42
oligos) from the EGFP gene were assembled using the One-Step PCA protocol. Robustness of assembly for
varying concentrations of oligo pool (I -50 nM each) was assessed. 4 uL of each PCA product was run on
the 1%agarose gel alongside 2 uL kb ladder (Stratagene). All images were enhanced for contrast with the
same parameters.
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Figure 8 One-Step PCA of EGFP fragments with various polymerases at varied oligo pool concentrations.
Target DNA constructs of length 545 bp (20 oligos), 1075 bp (38 oligos), 1621 bp (56 oligos), 2163 bp (74
oligos), and 2406 bp (90 oligos) from the Tma MutS gene were assembled using the One-Step PCA
protocol. Robustness of assembly for varying concentrations of oligo pool (I-50 nM each) was assessed. 4
uL of each PCA product was run on the 1%agarose gel alongside 2 uL kb ladder (Stratagene). All images
were enhanced for contrast with the same parameters.
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Figure 9 One-Step PCAvs. Two-Step PCA for constructs of various sizes with Phusion polymerase.
Target DNA constructs of length 264 bp (12 oligos), 475 bp (22 oligos), 682 bp (32 oligos), and 993 bp (42
oligos) from the EGFP gene and of constructs length 545 bp (20 oligos), 1075 bp (38 oligos), 1621 bp (56
oligos), 2163 bp (74 oligos), and 2406 bp (90 oligos) from the Tma MutS gene were assembled using
either One-Step PCA (with 10 nM each oligo pool concentration) or Two-Step PCA using Phusion
polymerase (Finnzymes). Robustness of assembly was assessed. 4 uL of each PCA product was run on the
1% agarose gel alongside 2 uL kb ladder (Stratagene). All images were enhanced for contrast with the
same parameters.
Parsing the sequence
We recommend the use of a software parsing tool such as DNAWorks
(http://molbio.info.nih.gov/dnaworks/) for gene synthesis in order to optimize for consistent
melting temperature, hairpin formation, no self-annealing, no primer-dimerization, codon
frequency in host organisms, and more. In our experience, this software has been very easy to
use and has given us reliable results. Oligonucleotides that are parsed with DNAWorks seem to
build with greater robustness in One-Step peA.
Error ratefrom the gene synthesis process: Vendor comparison
We found that the error rate of synthesized DNA depended greatly on the quality of the
oligonucleotides ordered commercially. Vendors were seen to vary dramatically in the suitability
of their oligonucleotides for gene synthesis.
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The primary error In chemical oligonucleotide synthesis is a failure to add a new
nucleotide monomer to the growing chain (synthesized 3' to 5') - this causes a deletion.
Oftentimes, this error-product will be capped with an acetyl group, preventing further additions
to the chain. This results in a shortened oligonucleotide, but there is no mutation actually
incorporated into the DNA, so these truncated products do not add any errors to the final product
in gene synthesis. This is evidenced by the fact that while average stepwise yields for oligo
synthesis are roughly 99% (1% error), use of these oligos in gene synthesis results in an error
rate of only about 0.2% - many of the dominant errors in oligo synthesis are masked by the peA
process. However, sometimes the acetylation step fails, and the growing nucleotide chain ends
up with a deletion. The result of this is the incorporation of a deletion into the synthetic DNA in
gene synthesis. Single base deletions are the most common type of error found in our sequencing
data.
We compared synthetic EGFP built from oligonucleotides ordered from many different
vendors via flow cytometry and sequencing analysis. (See Table 1 and Figure 10).
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Flow Cytometry (GFP): Oligo vendor comparison
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Figure 10 Flow cytometry data: Oligo vendor comparison
EGFP was synthesized using Two-Step PCAwith oligos from five different vendors. The products were
cloned with Clonase II (Invitrogen). transformed. cultured. and analyzed by flow cytometry as described
earlier. All% fluorescent cells measurements were normalized to the % fluorescent cells measurement of
cells expressing a perfect. sequenced copy of the pDONR221-EGFP plasmid to account for run-to-run
variation. Oligos from MWG. IIIumina. Sigma. IDT. and the first set of Operon oligos were parsed
"naively" into SOmers. The second and third sets of Operon oligos were parsed using DNAWorks 3.0.
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Flow Cytometry (GFP): Polymerase comparison
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Figure 11 Flow cytometry data: Polymerase Comparison
EGFP was synthesized using Two-Step PCAwith oligos from lOT and a panel of different polymerases:
PfuUltra II (Stratagene), Phusion (Finnzymes), Pfx50 (Invitrogen), PfuTurbo (Stratagene), BO Advantage
2 (Clontech), Taq (NEB), and Titanium Taq (Clontech). The products were cloned with Clonase II
(Invitrogen), transformed, cultured. and analyzed by flow cytometry as described earlier. All% fluorescent
cells measurements were normalized to the % fluorescent cells measurement of cells expressing a perfect,
sequenced copy of the pOONR221-EGFP plasmid to account for run-to-run variation.
While an exhaustive survey of batch-to-batch variation from each of these vendors was
not within the scope of this work, our results from lOT are consistent with that which we have
seen in the past - we have consistently seen low error rates in the range of 1 in 500bp to 1 in
700bp with excellent reproducibility from lOT. Oligos purchased from Sigma also seem
promising for gene synthesis with an error rate comparable or slightly better than lOT, but we
did not choose to assess batch-to-batch variability at this time and would recommend IDT over
Sigma for most users for the time being. Operon seems to have excellent potential for producing
oligonucleotides of high quality (the first batch we got from them gave us an error rate of 1 in
1500 with matching FACS data, prompting us to order another set from them), but they seem to
have a problem with variability in quality. After speaking with Operon representatives about the
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relatively low quality of the second set of oligos ordered from them, they agreed to send us
another set on a machine they use primarily to produce oligos for gene synthesis applications.
We refer to this third set as "Operon 2 New" or "Operon 2nd resent". (Note: the second and third
sets of oligonucleotides from Operon were parsed using DNAWorks, all other oligos were parsed
identically, into 50mers without any optimization). The third set of oligos yielded product with
an intermediate error rate on the order of 1 in 1000.
Thus, for the average user, we recommend ordering oligos from IDT for most common
gene synthesis applications.
Error rate from the gene synthesis process: Polymerase comparison
We also studied the effect of using various polymerases - some high-fidelity such as
PfuTurbo (Stratagene) and some non-high-fidelity such as Taq - and found that most high
fidelity (proofreading) PCR polymerases make negligible contributions to the overall error rate
of gene synthesis. On the other hand, the use of Taq polymerase or Taq-based blends (often used
for long templates in PCR) contributed substantially to the error rate of gene synthesis. We again
used flow cytometry and sequencing as our main readouts for error rate.
Figure 11 shows the performance of various polymerases for gene synthesis in our GFP
flow cytometry assay. It is important to note that this functional assay by flow cytometry is not a
good readout for substitution errors and silent mutations because these types of errors may not
abolish function. On the other hand, a functional assay is very good for detecting the single base
deletions that are so prevalent in gene synthesis.
Within the limits of our assay, all non-Taq polymerases tested gave similar performance.
We confirmed our results by sequencing analysis. Sequencing confirmed disastrous error rates
for Taq (NEB) and BD Advantage 2 (Clontech), a Taq-containing blend, of 1 in <100bp.
PfuTurbo Hotstart (Stratagene), Phusion (Finnzymes), and Pfx50 (Invitrogen) yielded similar
error rates (-1 in 600 with IDT oligos), while Pfu Ultra II Fusion sequencing yielded a roughly
500/0 higher error rate (about 1 in 400 with IDT oligos).
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Protein-mediated error correction for synthetic DNA by MutS gel-shift
Fragments of EGFP were synthesized and then thennally denatured and re-annealed to
re-assort errors and create error heterodimers. MutS was observed to selectively bind error-
containing DNA and cause a gel-mobility shift in polyacrylamide gel. The DNA was visualized
by staining with SYBR Gold. As can be seen in Figure 12, the error-containing DNA can be seen
as a shifted band of reduced mobility. The MutS-filtered DNA, the MutS-bound DNA, twice-
MutS-filtered DNA, and appropriate controls were amplified and analyzed by flow cytometry,
green/white colony count and sequencing.
FACS analysis (see Figure 13) showed substantial improvement in fluorescence in those
samples that were error-filtered, both in tenns of percent green cells as well as in mean intensity
of green fluorescence.
Figure 12 MutS pull-down filter.
Lane 1: kb ladder. Lanes 2,3,4,5: -300mer pieces of GFP (993bp), treated with MutS. Lanes 6,7,8,9:
Same as lanes 2,3,4,5, except without MutS treatment. (From Carr et aI., 2004)
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Figure 13 FACS data for GFP synthesized with MutS pull-down error ftlter
(from Carr et al. 2004)
(A) Effect of error removal on GFP gene synthesis. Flow cytometry measurements of cells expressing GFP
from synthetic genes. Error removal as shown in Figure 2 has been used to improve the quality of the
synthesis products. Horizontal axes indicate fluorescence intensity specific to this gene, while vertical
axes indicate nonspecific fluorescence at a different frequency. Thus, cells which contain successfully
synthesized GFP genes are expected to display a minimum level of fluorescence at 530 nm, and
substantially less fluorescence at 585 nm (the bounded region in the lower right of each graph). Higher
contours (lighter plot color) indicate greater density of cells at a given coordinate. Negative control:
expressing a non-fluorescent gene (Tet) in the same vector; Error-enriched: GFP genes produced from
MutS-bound DNA fragments; Standard: GFP genes produced by conventional gene synthesis, with no
additional processing to remove errors; Error-depleted: GFP genes which have undergone one cycle of
error removal; Depleted twice: after two cycles of error removal; Positive control: a correct copy of the
same GFP gene, in the same vector. (B) Mean fluorescence intensity of each population of cells (50,000
per experiment) as a function of the proportion of fluorescent cells (those in the cut -off region indicated in
panel A). Each application of the error-removal process yields an improvement in the quality of the
synthetic genes. (black circles): negative control; (yellow triangles): error-enriched; (black square):
standard; (red diamonds): 'untreated' DNA subjected to the same manipulations shown in Figure 2, but
without the application of MutS protein; (blue circle): DNA error-depleted once using MutS protein;
(black triangles): the same GFP DNA employed for the positive control, but amplified by PCR and re-
cloned; (purple square): depleted twice; (black diamonds): positive control. Values have been normalized
to the mean intensity of the positive control (set at 1). Color symbols indicate sets which were subjected to
DNA sequencing and correspond to the symbols shown in Figure 14.
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Sequencing data was used to quantitate errors and characterize the types and locations of
errors surviving the error-filtration procedure. Error rate was decreased ~ 15-fold in two cycles
of the filter protocol from a standard error rate of about 1 in 600 to about 1 in 10000 .
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Figure 14 Locations of errors within the GFP DNA synthesis product - MutS pull-down error filter
(from Carr et aI. 2004). From bottom to top: the overlapping set of 38 oligonucleotides (thirty-six SO-
mers and two 5'-terminal S9-mers) used to build the GFP gene and flanking sequences (arrowheads
indicate the 3'-terminus); the four intermediate assembly products used for the first round of error
depletion; positions of errors present in the error-enriched (EE, yellow triangles), untreated (UN, red
diamonds), error-depleted (EDl, blue circles), and twice depleted (ED2, purple squares) gene synthesis
products. Per-base error rates are indicated.
error type error-enriched untreated error-depleted depleted twice
deletion
single deletion
-O/C 47 28 1 0
-AJT 18 9 0 I
multiple deletion 25 4 6 0
insertion
single insertion
+O/C 4 0 0 0
+AJT 3 3 0 0
multiple insertion 0 0 0 0
substitution
transition
O/C to AJT 10 9 1 I
AJT to O/C I I 0 0
transversion
O/C to C/O 4 6 0 I
O/C to T/A 0 2 2 1
AJT to C/O 0 0 0 0
AJT to T/A 0 I 0 0
otber
OAtoT 0 0 0
total errors 113 63 10 4
bases sequenced 37,440 35,977 38,103 39,080
error rate (per base) 0.0030 0.0018 0.00026 0.00010
Table 2 Summary of errors in GFP gene synthesis - MutS pull-down error filter (from Carr et al. 2004).
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Discussion
Critical Variables and Considerations in Practical Gene Synthesis
The results of our work in developing a universally effective, robust, and simple gene
synthesis protocol allow us to make some broad recommendations for the average gene synthesis
user for most applications. We have shown that three of the most important considerations in
gene synthesis are the choice of protocol, the commercial source of oligonucleotides, and the use
of a high-fidelity polymerase.
First, Two-Step PCA is an easy-to-use and straightforward protocol that is effective and
robust (it is forgiving of wide variations in oligo pool concentration, for example). On the other
hand, while One-Step PCA has its advantages, such as reduced sample handling and shorter
overall assembly time, in general situations, the shortcut is not worth it because optimizing and
troubleshooting a failed procedure is usually significantly more time-consuming than running the
protocol itself. Also, as one can see highlighted in yellow in the Gene Fabrication time pie (see
Figure 15), the time spent doing gene assembly in the overall process of Gene Fabrication is so
small that the extra time and labor spent performing the Two-Step PCA vs. the One-Step PCA is
negligible.
Computer aided target and
oligonucleotide design
2
24+
Figure 15Gene Fabrication: Process Time Pie
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Second, we have shown that making a good choice for the commercial source of
oligonucleotides for gene synthesis is of great importance, as the quality of the oligo can be the
dominating source of error in gene synthesis (with use of a high-fidelity polymerase, discussed
next). Sigma and Operon are both promising, but the latter exhibits great variability and the
former has not yet been thoroughly studied for batch-to-batch variation. For most applications
(target length", lOOObp), we recommend the tried-and-true oligo vendor IDT for an overall error
rate in the range of 1 in 500bp to 1 in 700bp. If the user can discuss one's needs with the
company and get high quality oligos from Operon with less variability, that could be a useful
option. Given batch-to-batch variability of Operon oligos at present though, for building longer
constructs or in other applications requiring lower error rates, we would recommend building the
target in overlapping '"1OOObp pieces with the more reliable and reasonably high-quality IDT
oligos and following up the procedure with an error correction protocol such as a MutS-mediated
gel-based error-filter. We have demonstrated an error rate improvement to 1 in 10000bp starting
from 1 in 600bp in two cycles of this procedure (see next section).
Finally, choosing a high-fidelity polymerase that is robust in gene assembly PCA is
absolutely critical. Taq and BD Advantage 2 (a Taq blend) gave error rates that were
unacceptable for gene synthesis applications (see Figure 11 and Table 1). Of the commercially
available polymerase we used, we recommend the use of Phusion (Finnzymes). It performs quite
well in both One-Step PCA and Two-Step PCA, has reduced cycle times (less than half the
time), requires half as many units per reaction, and demonstrates low error rates for gene
synthesis. It is also in the "new generation" of polymerases that fuse the traditional thermophilic
proofreading polymerase to a domain for improved processivity.
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Figure 16 GFP green/white colony count comparing three data points demonstrating the importance of
choosing optimal parameters for successful gene synthesis.
GFP green/white colony count was performed with cultures from cells transformed with gel-purified
product from Two-Step peA performed with the following oJigos and polymerases (from left to right): lOT
oJigos / Taq (NEB) polymerase; IDT oligos / Phusion (Finnzymes) polymerase; Operon (3rd set) / Phusion
(Finnzymes) polymerase. Plates were imaged on a Fluorchem8900 gel documentation system (Alpha
Innotech) under UV illumination (365 nm) with a SYBRGreen filter. Adobe Photoshop was used for
image enhancement (gamma setting -3,white/black threshold adjusted for optimal contrast, false color
green). The same image enhancement settings and camera exposure settings were used for all samples.
As one of our primary assays, flow cytometry is a useful qualitative and semi-quantitative
tool that allows us to sample large populations of cells at once. However, in our experience, we
have often seen substantial sample-to-sample variation on the order several percent (%
fluorescent cells). Normalizing against a pEOFP positive control is useful for data analysis and
comparing data sets. Machine run-to-run variability with the same sample, however, is very low
(less than 0.5%). We hope to continue to improve our knowledge of OFP flow cytometry as a
useful tool for assessing error rates in gene synthesis. Some considerations include staining dead
cells with propidium iodide or another marker to more effectively analyze only live cells (we
currently rely on forward and side light-scattering distributions), filtering our media for
particulate matter, and using higher quality culture media.
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Protein-mediated error correction for synthetic DNA by MutS gel-shift
Error rates are a significant barrier to the construction of large DNA targets. For example,
the 7501 bp poliovirus synthesis was achieved at great cost and required many months, largely
due to the multiple iterations of assembly and sequencing needed to yield the correct product
(Cello et al 2002). By contrast, a 2703 bp plasmid synthesis (Stemmer et a11995) and a 5386 bp
bacteriophage phiX174 synthesis (Smith et aI, 2003) were relatively rapid and inexpensive, but
required targets which were easily selected for function (such as antibiotic resistance, or a viable
genome) and thus are not general to most DNA synthesis goals.
The method described here and reported in Nucleic Acids Research in 2004 demonstrates
a 15-fold reduction in error rates to 1 in 10,000bp. Referring back to Figure 3, one can see that
this improvement in error rate allows for the synthesis of targets on the order of 10kb. Or, more
dramatically, it should be possible to synthesize a 5000bp target, error correct it, clone it, and
sequence only three clones to have very high probability that it will be error-free. A case in
point: we generated the Taq MutS gene using this error correction protocol, sending off only one
clone for sequencing, which came back perfect. When we had previously tried to synthesize
correct DNA products of this length, the process required two cycles: we generated smaller
pieces of the overall construct, cloned and chose perfect constructs by sequencing, and then
assembled the full-length target from the perfect smaller pieces and cloned and sequenced again.
One can see that production of even a moderately large gene target without error correction can
take substantial labor, time, and expense (especially for additional sequencing reactions
necessary for the higher error rate).
Analysis of the sequencing data gave some interesting information for follow-up study.
Based on what is known about MutS protein affinity for different types of DNA mismatches
(Whitehouse et aI, 1997; Brown et ai, 2001), one may expect some errors to be removed by this
protocol better (or worse) than others. However, reductions in all categories of errors were
observed in our results (See Table 1). Deletions are the dominant form of error in untreated
samples (59%), especially single base deletions (44%). The reduction in this category is the most
dramatic: for the twice-depleted products only lout of 4 errors was a deletion. Of greater
surprise was the absence of longer deletions in the twice-depleted products. MutS proteins are
not known to bind well to heteroduplexes with deletions longer than 4 bases (Whitehouse et aI,
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1997). In contrast, longer deletions were observed in the error-enriched (MutS-bound) fraction-
several deletions 5 or 6 bases in length, and one 54 bp deletion.
The distribution of error locations within the sequence also changes as a result of MutS
treatment (see Figure 14). For the errors which survived the removal procedure, a bias is seen
towards the ends of the DNA product, i.e. where PCR primers were used for final amplification
after error removaL These account for 43% of the errors in these groups, in a region which is
only 12% of the total sequence. (In untreated samples, 11 % of the errors fall in this region-
there is no apparent bias.) Thus it seems likely that the final amplification is introducing some
low level of errors through the PCR primers. In addition, the DNA polymerase used for PCR has
the potential to introduce errors. Data shown in Figure 3B is consistent with this hypothesis. Two
cycles of error correction brought the overall error rate to roughly the same level as one of the
control experiments, a correct copy of the gene which was simply PCR-amplified and re-cloned
into the same Vt~ctor. Some bias in error location is also observed in favor of errors at the ends of
the four gene fragments which underwent the first round of error-depletion, followed by final
assembly and atnplification (Figure 14). Many of these errors are within 15 bp of the edge of the
DNA duplex, inlplying MutS binding at these edges may be less effective. These errors are not
observed after the second round of error-depletion, performed on the full-length product (Figure
14).
Possible directions for improving on this protocol in terms of improved error rate,
decreased sample handling, amenability to automation, and more are discussed in the following
section.
Follow-up material to MutS gel-shift error correction: Initial Results
To date, our results show the best error rate published so far in the literature. Figure 17
shows a side-by-side comparison of three methods of DNA error reduction published (ours and
two published subsequently by other groups). The Belshaw group demonstrated a protocol for
error correction called consensus shuffling in which synthetic DNA is fragmented with a variety
of restriction endonucleases, error-filtered via binding to immobilized MutS, and re-assembled
via PCR (Binkowski et al 2005). Two iterations of the process decreased errors 3.5- to 4.3-fold
to final values of ~1 in 3500. The Hegemann group demonstrated a novel strategy for error
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reduction in cloned synthetic DNA by applying enzymatic mismatch cleavage with the
resolvases T4 endonuclease VII or E. coli endonuclease V at the site of errors and using an 3'-5'
exonuclease (or the 3' -5' exonuclease activity of proofreading polymerases) to remove the error
(Fuhrmann et aI, 2(05).
Further improvements in error rate will be helpful in enabling the use of gene synthesis
technology in applications requiring large DNA constructs as described earlier.
At present, preliminary experiments have been completed to make improvements on the
MutS gel-shift error correction described above and reported in Nucleic Acids Research in 2004.
Some of the inlprovements we have been working on, many of which are noted in the 2004
report, include: use of PCR primers (containing cloning sequences) that lie outside of the coding
sequence of the gene target sequence to prevent errors from final PCR amplification steps after
error reduction protocols, optimizing the parameters of the MutS error-filtration protocol to work
with longer pieces of DNA so as to mitigate end-effects (the footprint of MutS, determined by
DNase I footprinting by Biswas and Hsieh (1997), is ~24-28bp), further characterizing the
optimal stoichiometry for MutS binding to DNA, and the development of separation techniques
other than polyacrylamide gel (time-intensive, not automatable) such as attaching MutS to solid
supports such as resins or magnetic agarose beads and sedimenting by centrifugation or applying
a magnet. We have also synthesized the genes for two hyperthermophilic variants of MutS from
Thermatoga maritima and Aquifex aeolicus and successfully expressed the proteins in E. coli.
We have been characterizing the properties of these proteins, especially in regards to their
potential utility in error reduction protocols for gene synthesis.
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Figure 17Comparison of three methods of DNAerror reduction.
MutS error-filtration described in this document (Carr et al 2004) (red triangles),
consensus shuming by Binkowski et al 2005 (purple squares), and enzymatic mismatch
cleavage by Fuhrmann et at 2005 (blue diamonds). Times are estimated.
Characterization of new MutS variants: Preliminary results/discussion
As mentioned above, we have constructed the genes for MutS genes derived from other
species (from Thermotoga maritima-"Tma MutS," and Aquifex aeolicus-"Aae MutS"). We
have assessed the thermostability of these proteins from hyperthermophilic organisms using a
temperature scan with circular dichroism. The observed melting temperature of Tma MutS and
Aae MutS are about 82°C and >95°C, respectively. This property of the two proteins makes them
promising candidates for high-temperature reactions such as for error-prevention reagents in
PCR.
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Figure 18 Circular dichroism spectrum of Tma MutS compares favorably to that of
Takamatsu et at. 1996 for T. thermophilus MutS
We plan to use the new MutS proteins for a number of efforts in error correction. First
off, we plan to compare them to Taq MutS for error-binding characteristics and general error
removal post-gene synthesis. Both proteins have shown function in gel mobility shifts of
mismatched DNA. Initial GFP flow cytometry results indicate that Aae MutS may improve error
rate as much as 15-fold in one cycle. It is possible that the new variants of MutS have improved,
or at least different, perfonnance characteristics (affinity, specificity) for error-binding - as a
case in point, MutS from Thermus thermophilus, HB8 was found to have broader specificity for
mismatches than E. coli MutS (Whitehouse, 1997). Multiple species of MutS might complement
each others' strengths and weaknesses for optimal error removal.
We are also in the process of further characterizing the error-binding properties of these
MutS proteins with two different tools: surface plasmon resonance (SPR) and Fluorescence
Correlation Spectroscopy (FCS) with the Olympus MF20 - an instrument that makes ingle
molecule fluorescence measurements within the volume of a confocal field. In the latter
approach, fluorescently labeled oligos can be observed in the presence of varying amounts of
MutS protein to get a measure of binding affinity for different types of mismatches (AA, CC,
GG, TT, AC, AG, CT, GT, single base deletions/insertions ).
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MutS attached to solid supports: Preliminary results/discussion
We now have some preliminary data on error-filtration using MutS attached to solid
supports via affinity tags. We expect such methods to outperform the current approach using gel
electrophoresis in terms of both speed and ease of implementation. One of the advantages of a
quick protocol is that it can be iterated multiple times to yield better and better error rates (up to
a certain threshold).
Our recombinant MutS proteins have N-terminal polyhistidine tags used for protein
purification following expression. Our preliminary results suggest that MutS can simultaneously
bind to both Ni··NTA (or Ni-NDA) conjugated beads or resins and DNA mismatches. We have
noted better performance with DNA of shorter lengths, however, with 70mers binding better than
400mers binding better than 1000mers. Our immobilized Tag MutS gave no evidence of
preferentially binding to 1000bp error-containing DNA vs. error-free DNA.
These results are similar to those of Geschwind and co-workers (Geschwind et aI, 1996),
who fused E. coli MutS to an N-terminal biotinylated peptide domain for mutation detection with
streptavidin-coated beads. They observed ~4-fold discrimination of mismatches for 400 bp
DNA, and saw no discrimination at 1400 bp. Similarly, Binkowski et al. later showed a modest
~~2-fold improvement of a pool of synthetic GFP DNA using a MBP-MutS (Tag) fusion protein
for error reduction in synthetic genes (Binkowski et aI, 2005).
While non-specific binding of MutS to DNA is definitely a concern and is a likely a
contributing factor in the decreased efficiency of differential binding by the immobilized MutS
by our group and others, the fact that our MutS-mediated gel-based error-filtration protocol
yields substantial error-rate improvement gives us reason to believe that an effective
immobilized-MutS error-filtration protocol can be developed. Recently, using one of our new
MutS variants (from Aquifex aeolicus), we have observed as much as 15-fold improvement in
error rate in ont~ cycle of the gel-based error-filter. In recent work, Erie and coworkers studied
nonspecific MutS binding from an imaging / statistical approach by observing DNA binding on
MutS by atomic force microscopy and found that a high fraction of non-specific binding occurs
at DNA ends (Yang et aI, 2005). This is encouraging for us because the number of DNA ends of
a linear molecule (two) does not increase with the length of the construct. One way to block non-
specific end-binding of MutS to DNA is to add bulky end-modifications such as streptavidin on
end biotinylated DNA.
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We hope to design an improved immobilized-MutS error-filtration protocol in a number
of ways. First of all, we have noticed that the two new MutS variants we have recently
synthesized and expressed appear to have improved binding characteristics for larger DNA while
bound to Ni-NTA resin. This could have to do with the characteristics of the proteins themselves
(w'e are in the process of characterizing the proteins with techniques such as SPR, circular
dichroism, and Fluorescence Correlation Spectroscopy), or it could have to do with steric
considerations: the new MutS proteins have linkers between themselves and their His-tags of 10
amino acids (pET-I5b vector) whereas the Taq MutS protein has only a linker of 2 amino acids
(Gly-Gly). DNA-binding occurs relatively close to the N-terminus, where the His-tags are
located. As a first experiment, we are planning to subclone the Tag MutS protein into the pET-
I5b vector to give it the same linker as the other recombinant MutS proteins. By experimenting
with this constnlct, we hope to determine the relative importance of linker length on the binding
characteristics of immobilized MutS.
Other possibilities for immobilizing MutS on solid supports include utilization of any of a
variety of affinity tags and domains (CBD, GST, strep-tag, S-tag) or chemical cross-linkers (via
thiol groups on cysteine residues engineered into the protein sequence at appropriate locations
via gene synthesis or mutagenesis techniques). These affinity tags/domains or crosslinking
groups could be placed on the C-terminus or the N-terminus of the MutS protein (or in the case
of a cysteine residue for crosslinking, anywhere on the protein).
Weare also interested in the effect of using our different variants of MutS in developing
this approach. In preliminary results, we have noticed that A. aeolicus MutS seems more
effective than T. maritima MutS at separating mismatched 1000mer DNA while bound to Ni-
NTA resins. Estimates from monitoring flow-through by UV absorbance (OD22onm) and PAGE
show approximately four-fold preferential binding of mismatched 1000mercompared to its error-
free counterpart.. We will follow through with these results by flow cytometry and sequencing.
As a sidenote, we have had some concerns about improperly annealed DNA (e.g.
Holliday junction-like higher-order structures) being poorly bound by MutS in the immobilized-
MutS error-filter protocol. In the gel-based assay, such higher-order structures have such poor
mobility that they effectively remove themselves from the error-filtering by migrating only a
small distance (or not at all) through the gel. In an immobilized-MutS error-filter system, such
DNA - which would never have been treated for error-reduction - could presumably make it
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through the filter and reduce the overall effectiveness of the protocol. One might consider filter
membranes to exclude higher-order structures, the use of resolvases to resolve those structures,
or other methods, if it turns out that this is an important problem to deal with in optimizing this
protocol.
This also brings up the issue of the dependence of error reduction efficiency on DNA
target sequence (apart from the usual discussions of differential binding specificity of MutS to
different types of mismatches). As a consequence of the possibility that MutS does not bind well
to higher-order structures of DNA, sequences containing repeats, palindromes, or other
sequences conducive to DNA secondary structure-formation may be somewhat poor targets for
error reduction. In these cases especially, it may be helpful to develop and utilize methods for
excluding, reducing, or resolving higher-order DNA structures prior to error correction. A
number of simple initial experiments investigating sequence dependence of error reduction
efficiency are advisable.
Optimizing MutS stoichiometry and binding conditions: Preliminary results/discussion
In the MutS gel-based filter, we observe differing amounts DNA in the "unbound" error-
depleted band in the gel depending on the relative amounts of MutS and DNA used in the
procedure. Preliminary data via GFP flow cytometry suggests that using increasing amounts of
MutS to get fainter and fainter bands improves the error rate of the surviving pool. This issue,
and others concerning the optimal stoichiometry for MutS-DNA interactions in error-reduction
protocols, deserves consideration in future work.
51
Conclusions / Recommendations
Gene Synthesis
Gene synthesis holds promise as a remarkably powerful tool to not only make current
research efforts requiring DNA manipulation more productive and efficient, but also as a
technology that will enable entire new fields of research that require long constructs, custom-
designed DNA molecules, or large sets of designed constructs.
This document gives a set of recommendations for a robust, quick, and easy gene
synthesis protocol for the typical user. Among the most important considerations were protocol
choice, oligo vendor, and polymerase choice. We demonstrate a Two-Step PCA protocol that
gives reasonably low error rates (assayed for 1000bp construct) and robust building for gene
products up to at least 2.5kb in length (90 oligonucleotides).
There appears to be a ceiling for the best error-rate achievable (without error correction)
around 1 in '"1500bp (possibly better, given the uncertainty of our error rate measurement with
the number of bases sequenced). With the use of a high-fidelity polymerase, it seems that oligo
synthesis errors dominate this overall error rate. There may be room for newly optimized
chemistry development for oligo vendors, though much optimization has already been done. If
so, we can expect to be able to push the overall error rate of the gene synthesis process even
lower.
Future \vork should explore the optimization of gene synthesis protocols for use in
specialized circumstances, such as in microfluidic devices coupled to DNA microarrays (a
remarkably economical source of oligonucleotides that could help push down the price of gene
synthesis several orders of magnitude). Because reduced sample-handling may be important, use
of One-Step PCA or other protocols may be better in the case of these devices, even though we
recommend Two-Step PCA for normal, in vitro benchtop gene synthesis.
Error Correction
It was noted above that at present, '"1 in 1500bp may be the best gene synthesis error rate
we can achieve, given errors due to the oligo synthesis process. However, achieving better error
rates is of pararrlount importance in opening up the use of gene synthesis for some of the more
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ambitious objectives laid out in the Introduction section. This points to the necessity of
developing improved post-synthesis error correction protocols. While our demonstrated MutS-
mediated gel-based error rate reduction (~15- fold) from 1 in 600bp to 1 in 10000bp is
significant, there is still much room for improvement. Future work will continue to push the
limits of error rate reduction using strategies involving MutS as well as a number of other
candidate proteins.
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Figure 19 The effect of mismatch cleavage followed by amplification.
The fate of a given error (pink triangle, strands containing errors shown in pink) is
followed through cleavage of (A) both strands on each side of the mismatch; (B) both
strands 3' to the mismatch; and (C) both strands 5' to the mismatch. In each case,
propagation of the error into full length strands is retarded relative to amplification of
uncleaved material.
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MutS dimer
Fokl-N Fokl-N
Figure 20 Schematic of a mismatch
endonuclease designed for gene
synthesis error correction.
It is composed of domains from MutS
and FokI proteins. MutS binds as a
dimer to a DNA mismatch, positioning
the FokI nuclease domain to cleave both
strands of DNA on each side
Some of our future directions are obvious extensions of our MutS gel-based error-filter
protocol. These are described in some detail and some preliminary data is given in the
Discussions section. Other future directions include the creation of a mismatch endonuclease by
fusing MutS to the nuclease domain of FokI, the use of said fusion mismatch endonuclease for
iterations of error reduction in PCR by cleavage followed by amplification (see Figure 19), the
use of various thermophilic resolvases for enzymatic mismatch cleavage methods (as in
Hegemann 2005), the use of MutS as a PCR-additive to block extension of error-containing
duplexes, and more.
The ideal error correction protocol will improve error rate substantially, be quick,
generalizable and easy to implement, require minimal sample-handling, and be an automatable
and iterative process. In terms of error rate improvement, the sky is the limit - in vivo systems
regularly maintain DNA fidelity with error rates as low as I in 108 bp to 1 in 1010 bp.
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Lt\.ppendix
peR recipe / thermocycling charts
One-Step PCA recipe
For PfuTurbo, BD Adv 2
uL Component
0.5 dNTP (10 mM each, stock)
0.4 pol (PfuTurbo or BDAdv2)
2 10X Buffer
2 Pool
2.4 Primers (2.5 uM each)
12.7 ddH20
ForPhusion
uL Component
0.5 dNTP (10 mM each, stock)
0.2 pol (PfuTurbo or BDAdv2)
4 5X Buffer
2 Pool
2.4 Primers (2.5 uM each)
10.9 ddH20
Thermocyc1ing parameters for EGFP constructs and --500bp and --1OOObp Tma MutS construct
guild
PfuTurbo
95°C / 2 minutes
Repeat 30X:
95°C / 30 seconds
55°C / 30 seconds
72°C / 1 minute
72°C / 10 minutes
4°C / Hold
BD Advantage ~
95°C / 1 minute
Repeat 30X:
95°C / 30 seconds
55°C / 30 seconds
68°C / 1 minute
68°C / 1 minutes
4°C / Hold
.Phusion
98°C / 30 seconds
Repeat 30X:
60
98°C / 10 seconds
55°C / 30 seconds
72°C / 15 seconds
72°C / 5 minutes
4°C/Hold
Thennocycling parameters for Tma MutS construct build (----1500bp, ----2000bp, 2406bp)
pfuTurbo
95°C / 2 minutes
Repeat 30X:
95°C / 30 seconds
55°C / 30 seconds
72°C / 3 minute
72°C / 10 minutes
4°C / Hold
BD Advantage 2
95°C / 1 minute
Repeat 30X:
95°C / 30 seconds
55°C / 30 seconds
68°C / 3 minute
68°C / 3 minutes
4°C / Hold
Phusion
98°C / 30 seconds
Repeat 30X:
98°C / 10 seconds
55°C / 30 seconds
72°C / 40 seconds
72°C / 5 minutes
4°C/Hold
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Two-Step PCA recipes and thermocycling (PCR 1 = Assembly PCR. PCR 2 = Amplification
PCR)
GFP peR 1 20 uL total
REACTlOfl MIXTURE PCRP OGRAIIIlJU cyclKl
luL.(10 In~1
mM d!nfly,1ljon 1M
NAME OUGOS uL dHTP ""chi POL\1lfERASE BUFFER uL WATER DENATURE AhWEAl EXTEHO fmil 'l!tJnIion
4Om!r MWG40 2.0 1'OtTn .. 1 0.4 PFU ILlrbo 0.4 PFU ILlrbo 2.~ 15.2 1;5" 0:30 ~" 0:30 72' '::l~ ~12Tr1n. 721 lOmin
~ 1Mw00l 2.0 IlOlTOaI 0.4 PFU ILlrbo 0.4 PFU ILlrbo B 15.2 ~" 0:30 ~" 0:30 72" 1:0~ \l!512min. 721 IOmin
eon- MWGClO 2.0 n<llma! 0.4 PFU ILlrbo OA PFUlLlrbo 2.0 152 ~" 0:30 !>5" 0:30 72' 1:0~ ~1:1n'ln. 721IOmin
Is.nm ......... Is-u. 2.0 normal 0.4 PFU ILlrbo 0.4 PFUILlrbo 2.0 15.2 ills" 0:30 ~" 0:30 72' 1:0~ ~nm.n. 72110min
o--on OIioos Ioc.ron 2.0 notmal OA PFU ILlrbo 0.4 PFUturbo 2.0 152 ills" 0:30 e.5. 0:30 72' 1::l~ ~/:1n'ln. 721 IOmin
11IwmI .. Oliao. [1fM1n>gtn) lIIumin .. 2.0 ncrm.ol 0.4 PFU ILlrbo 0.4 PFUturbo 2.0 15.2 iIl5" 0:30 55. 0:30 72' 1:0S Q!5/ n.721tOmin
normal 10HO 2.0 notmal 0.4 PFU ILlrbo 0.4 PFUturbo 2.0 15.2 tl5" 0:30 ~,5. 0:30 72" 1:Q~ Q!512mJn. 721 IOmin
old dNT? IOT50 2.0 old 0.4 PFU ILlrbo 0.4 PFUturbo 2.0 152 ~" 0:30 ~" 0:30 7~ toe \l!5/2mon.7211Omin
hez....:haw dNTP 10TSO 2.0 "-z ....i1_ H PFU ILlrbo 0.4 PFuiurbo 2.0 15.2 ~5" 0:30 e-5. 0:30 72' 1:0e Q!512mJn.7211Omin
2.0+20
KOO HiFi IOT50 2.0 ncrm.ol 0.4 KOO 0.4 KOO., MgC/2 13.2 k<4" 0:1S ~' 0:30 M' 1:05 11412nwo 08l2mn
PIx 50 IOT50 2.0 normal 0.4 PIx 50 OA PIx 50 2.0 15.2 1\;4" 0:15 ~" 0:30 !lS' 1::l5 11412".,n. 5812mm
Ta<> (NEill IOT50 2.0 ncrm.ol 0.4 Taa 0.4 Th!fmo 2.0 15.2 ~" 0:30 e.5" 0:30 72' 1:0e Q!5/2mln. 7212mm
PhUSl,," IOT50 2.0 notmaI 0.4 Phvsion 0.2 Phvsion HF 4.0 13.4 ills" 0:10 e.5" 0:30 72' ~:35 98/:!(}WC 72100-.."
TitanftJrnr .... lor50 2.0 ncrm.ol 0.4 Inr"", 0.4 TttT"", 2.0 15.2 !G5" 0:30 55" 0:30 M" 1:05 \l!5/ Ire n. 08l2rnn
SO Am.'lnfNI, ~ IOT50 2.0 notmal 0.4 BOAttv OA PCR bufftr 20 152 11;5" 0:30 ~..5' 0:30 !lS" 1::l~ \l!5/ '""n. 51!12rnn
PFU JI1ra IOT50 2.0 notmaI 0.4 PFU UIIra OA PFUUItra 2.0 15.2 k15" 0:30 e5. 0:30 72' 1:05 tl5/2min. 721 IOmin
()ptrnn 2nd, PfI.Tl.I!:<) Op..-on2nd 2.0 notmal 0.4 PFU ILlrbo 0.4 PFUturbo 20 15.2 "s" 0:30 ~~.0:30 72' 1::l~ \l!512rr,n. 721 IOmin
Inn-nn 2nd, PIx&! 0D!r0n 2nd 2.0 0<lllT1aI 0.4 PIx&! 0.4 PIx 50 2.0 152 k<4" 0:15 e.5" 0:30 M' 1:0e 1l4I2mJn,5812mn
~ 2nd, Phusion Oceron2nd 2.0 norm<>l OA Phu.ion 0.2 PhusionHF 4.0 134 ~" 0:10 ~5. 0:30 72. 0:3~ OB/20stK:. 721!rrlJ"l
lo.-nn 2nd. PlJLltr311 OMmn2nd 2,0 normal 0.4 PFU Ultra 0.4 PFULIlr.1 2.0 152 105" 0:30 ~" 0:30 72' 1::l5 Q!51:1n'... 721IOmin
aNT? abu5Q (4.; lOT50 20 n<lm1a14. 1.6 PFU turbo 0.4 PFUturbo 2.0 '4.0 5" 0:30 5S" 0:30 72. 1:0e \l!512rr ... 72' IOmin
...".,. ..11.....,50 IOT50 2.0 notmaI 0.4 PFU ILlrbo 0.4 PFUturbo 2.0 15.2 k;S" 0:30 ~5. 0:30 72' 1:05 \l!512mln. 721 IOm,n
Anneal IM'D 55 IOT50 2,0 norm<>l 0.4 PFU ILlrbo OA PFUlLlrbo 2.0 15.2 5" 0:30 ~5' 0:30 "2' ':O~ ~J:"'fn. 72' 1Jmin
Anneal I","" eo 10T~0 2,0 notmaI 0.4 PFU ILlrbo 0.4 PFUturbo 2.0 152 ~" 0:30 55" 0:30 i2' 1:0~ \l!512mm.7211Omin
Ol>eron~l!W. I'fuTurbo PPMln 2nd 2,0 n<llmal OA PFU turbo 0.4 PFUturbo 20 152 '5" 0:30 f.st 0:.>0 7:' 1::l~ ~/:r.-fn. 72'lOmin
Inn-nn~, PIx~O b-on2nd 2,0 normM 0,4 PIx 50 0.4 PIx 50 2.0 152 k<4" 0:15 E:!5t 0:30 ea' 1::l5 l14i2rr.n. 5&2"""
~~.Phu5ion be.rcn 2nd 2.0 n<lm1.a1 0.4 Phu.ion 0.2 Phusion'iF 4.0 '3.4 Ivs, 0:10 ~5t 0:30 72' 0:3~ OI3t20s.c. ,2JEro
~~_, PfuLl1rall botron 2nd 2.0 notmaI 0.4 PFUUItra 0.4 PFULItra 1.0 15.2 "5" 0:30 E5t 0:30 72' 1::le ll!51:1n'lO.7211Omin
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GFP PCR2 50 uL tolal
RE.\C1ION MIXTUIlE P<:R PROGIlAIII (30 cycIeIl Inlli.~-HAIlE PCRf tL tIHTP i.Il. F'Oll1llERASE lllA'l'ER lJl. FWDPRI'ER FlIIS PFWER WA~ DEHATtlAI! ~EAL I!XTfHO nAIl exlllMlon.ae.- r.fNG4ll ~5 /'IOIl'IIII 1.0' 1~1UtlO 1,0 "I"U:uma ,:1 1\MG4ll ~5 \lWGlO 2.5 1~5 \l:j" (JlI 55" I:.lll ,. 10!: 9S'21TIn 1211cmn
~tmef MNGSl :1.5 /'IOIl'IIII 1.0 05U1UtlO 1.0 Fru:uma 5:1 \AWGi5O :1.5 Wt'G<iO 2.5 J5.S ~. 0'30 !!- O:;l(l '. , O~ ~'2mn 72'1 em"
Ifl:flllf I~ ./.5 flClII1a I.CI I.... IUllO 1.0 ~ .. ;umo LL' 1..-1 ./.5 I~ '5 ."5.' ""'. :JI1 :5' :~ ~ 9S'2lTln. 72" I:rrlI1
SIclmiCIICICI ISIclmi 2.5 /'IOIl'IIII t.G ;>cIJ IUtlO ~.o Ffl.:uRlO 5:;- Isqni Z.5 ISXIlra 2.5 !5.S ~. 0'30 !S- O:;l(l 1ze , O~ ~12n1n '2'1 em"
locercn 0I0lI& Cceron 2.5 /'IOIl'IIII 1.0 P9J1UtlO 1.0 Fn.:uma 50 0De«:n :1.5 Opl!nlr 2.5 J5.5 95' 0'30 55- O:;l(l "'T 1~ ~S'2mn 12111:rrl1l
1I1lml11a OU!lC'
1I1"<111<:oen1- IlIJrrtra :1.5 natmaI 1.a ;>-\j IUtlO ~.O FI"l. :uRlO 50 UIJ'IlI'Ia Z.5 lIunl1a 2.5 !5.S 95' C'30 !S. O:;l(l ":- 1 O! ~5i2n'ln 72'lemn
n.....al I""'" 2.~ .......... 1./1 >'F\jn.M 1.a Fru""'" 0 no 2.5 lOTIO 2.5 .?S5 "",' 311 55' O:;l(l 7"- 10!: 95'2nln 72'1tmn
cllIONW 10T50 2.5 010 1.a ~1UtlO 1.0 FI'\. :urDll 5.:1 TI(J :1.5 lOTIO 2.5 JS.~ \l:j' CrJll !S. Q:;l(l 1 O~ 9S'2lTln 12'11:rrl11
~u.-
aNn' 11nT'i1l 2.~ ~ 1.0 PfUIlft<> ~,a PI'\. ......, 5.0 Il!lno '5 lOTIO 2.5 .?S5 95' 0'3:1 !S* Q:;l(l '2'" 1~ 95.'2lTln 12'1 Cmll
5.,.
50
KCOHFI IDr<>O 2.5 normal 1.0 '(00 1.0 KeD'" l,ltIC'2 IIOTI(J :1.5 lOTIO 2.5 JO.5 g,t. 0' I! !S. Q:;l(l ff' I O~ 9L'2lTln, fMll'ir
PIlCro 10,<>0 2.5 /'IOIl'IIII 1.0 IRXSl ~,a PIX&! 5.0 IlOno 2.5 lOTIO 2.5 .?SS ~" C,,~ !S. O:;l(l 66' 10! ~'21Tln fllo'2ll'in
[Taq
IfCno ce' 95.'2lTln. 12'2ll'inl=eaenEl I0T5D 2.5 natmaI '.0 T""..a ~.a lIE11l'O 5:1 2.5 lOTIO 2.5 J5.5 95' O'JlI O:~ 7Z' , O~
Pl!UIIoon 10,<>0 2.5 /'IOIl'IIII '.0 R1U1ICIl 0.5 I'I'UIon I'¥ fO.O TIO Z.5 lOTIO 2.5 ;n,o 98" III !S. O:;l(l 7'r 3! ~'JOUC. 7:Y5mtn
iitarllumTaa ID,<>ll 2.5 /'IOIl'IIII '.0 "T1Iba ~.o -tTaa 5.0 no 2.5 IO~O 2.5 !S.: 95' Cr3J !S. O:;l(l ft. 10! 05."mn fCl.'2ll'ir
llOICI'Ioruge
IDTIO ~ mn fllo'2ll'ir2 IDT5ll 2.5 /'IOIl'IIII 1.0 80MlI l.a FCRDUIIIr 5.0 Z.5 lOTIO 2.5 J5.: 95' ll'3O ~5. Q:;l(l ft. 10!:
PFL. JIR IDTSD 2.5 /'IOIl'IIII 1.0 09J UIrlI ~.a FfL. JIR 5.0 IIDTIO 2.5 lOTIO 2.5 !S.~ 95' IDa !S. O:;l(l 1:' 1(1~ 95.'2nln. 12:1 I:rrlIl
QIlenln Zr.CI.
Cte'llIl2l1J 10-011211 IQIenll\ 2IIlPI\oT\llllO 2.5 /'IOIl'IIII 1.0 Pf\J IUtlO ta Fn.:uRlO 5.0 Z.5 25 .?SS 95' 1t3:1 ~5" O:~O i'~ 1 O~ 9S'2lTln '2:1cml1
Ol:Enll'I2rCl.
looeran211 Ollefal'. 2IIl .."PfllSJ CCErnn2r :1.5 natmaI 1.a "'Ie ~Il ~.Q FfIl&! 50 2.5 25 .?S5 ~' co I! O:~ fe. 10! ~'2mn fll.'2ll'ir
O!=«C" 2rCI.
CCErnn2r 1<:»tr1:l'\211 1<»en:r.2IIlP!'~oon 2.5 noomaI '.0 r>I1ullCll 0,5 FI:ulmHF fO.O 2.5 2.5 J1.0 9a' It I~ .. Q:~O ':z" 1l3~ !i4'~OUC 1:t5frlr
IO~ercn 2r0,
CI:E!Ul2r 0!lfrCl' 211 Ollefal' 2IIlPMJIITJII :.5 normal '.a :"'uun :.0 Pfl. Jnra 50 Z.5 2.5 !5.! 95" C,3C _. O:~ 7:- 1 O~ 95.'2",n 72'1 Cm"
1aNT" al'IM
5~ 2.5 J2.S 95' UO ~5. o:~ ':- ho! ~'2lTln 12'1 em..,14x' IO,;>l! :1.5 /'IOIl'IIIIu .. ~1UtlO ~.~ FfL. :uma lOTIO Z.5 lOTIO
Arnealle'11p
[lnT"O ~..~ :>=IlhIto IJ!)T!(J45 nalT1lal t.O ~.O FfL. :uroc S~ Z.S IDTIO 2.5 JS.S 95' [; 3~ _. 0:<0 '. , a~ ~.s,l2r'T1:n 72" Cn",Arnealllmp
Ia:no .,...!O IDT5lJ Z.5 natmaI f.O =-u IUtlO '.0 Ffl. :uRlO S:1 Z.5 lOTIO 2.5 J5.! ~" Il 30 .. Q:~(J , O~ ~;5,'2nln 12'1 C",11
IArnealle'11p
!5 IDTSO 2.S namIaI 1.0' :>"U IUtlO ~.O Ff~ JJIlX 50 IlDno Z.5 lOTIO 2.5 !5.! \l:j' C' 3J _. O:&] '. , O! !;-05.'2mn 12'1 Cmn
~.
CIWIY11N 100000cr 211 1e-mn2ll<PI\oTlJtla 2.5 /'IOIl'IIII '.a ""U IUtlO ~.a FfL.JJmC 5.0 2.5 2.5 .!5.S 95' Cr30 _. O:~(J ':- 1 O~ !;-05.'2ITIn12'1 Cm"
Ol:~l!I/.
Ccer0n2111Fncro Z.5 nalT1lal 1.0 :>'lC!0' ~.O Ffll&l B o-cr 211 Z.5 Ollefal' 2n 25 35.5 9'-' C'I! _. O:~(J fe' . a~ ~'2mn to"2n1r
I~""
C.-m2N O!IIfcr211 <»et'CI'2IIlP!'~cn 2.5 noomaI '.0 ?IlU1ICIl 0,5 P1'u5Ol1 HC 10.0 2.5 2.5 :1'-0 9a' IlIJ -- Q:~(J 1:- C 3~ !i4'JO&ec ~'5rrlrIO~~"'.
C~2/11pn.ulRli :.5 nalT1lal t.~ :>"\) un ~.~ FI'L. JII,a 50 Ooer::r ~n Z.5 Ollefal' 2n 25 J5~ 95' OJ .- O:~(J '. ~Q! H'2nn 72', Cm"
Sequences
Taq MutS protein sequence
Taq MutS Construct DNA sequence (with flanking sequences included)
1
61
121
181
241
301
361
421
481
541
601
661
721
781
841
901
961
1021
1081
1141
1201
1261
1321
1381
1441
CATGCCATGGGCCATCACCATCATCACCACGGGGGTATGGAAGGCATGTTAAAAGGGGAA
GGACCAGGCCCTCTGCCCCCCCTGCTTCAGCAATACGTGGAATTGCGGGATCAATACCCG
GATTATTTGCTCCTCTTCCAGGTCGGTGATTTCTACGAATGCTTTGGGGAAGATGCAGAG
CGGCTGGCTCGGGCATTAGGACTCGTATTAACTCACAAAACCTCGAAAGACTTCACAACT
CCGATGGCGGGCATACCTTTGCGTGCGTTCGAGGCGTATGCTGAACGTTTATTGAAAATG
GGATTTCGGCTCGCTGTAGCCGATCAAGTGGAACCCGCAGAGGAAGCAGAAGGTCTGGTT
CGCCGGGAAGTTACCCAGCTCCTTACCCCGGGAACGTTGTTACAGGAAAGCCTGTTGCCC
CGCGAGGCTAACTATTTAGCAGCCATAGCCACAGGTGATGGGTGGGGATTAGCCTTTTTG
GACGTTAGCACAGGTGAATTCAAGGGAACTGTGCTTAAATCTAAGTCGGCTCTGTATGAC
GAGCTCTTCCGCCACCGTCCTGCGGAGGTCCTTCTCGCGCCTGAGTTGTTGGAGAACGGG
GCTTTCTTGGACGAGTTTCGGAAACGGTTCCCAGTCATGTTGAGTGAAGCACCTTTTGAA
CCAGAAGGTGAGGGTCCATTGGCTCTTCGTCGTGCGCGTGGCGCTTTACTGGCGTACGCC
CAACGGACTCAAGGAGGGGCGTTAAGCCTTCAACCTTTTCGGTTCTACGATCCAGGCGCT
TTTATGCGGTTACCGGAGGCCACTCTTCGTGCGTTAGAGGTGTTCGAACCCCTCCGCGGC
CAGGATACGTTGTTCTCAGTTCTGGACGAAACACGTACGGCTCCTGGCCGTCGTCTCCTT
CAAAGCTGGCTGCGCCATCCGCTCCTGGACCGCGGTCCCCTGGAGGCCCGTCTGGATCGC
GTCGAGGGATTCGTACGCGAAGGCGCTTTGCGTGAAGGAGTGCGGCGTTTATTATACCGC
TTAGCAGACCTCGAACGGCTCGCGACACGGCTGGAGCTCGGACGGGCTTCCCCGAAGGAC
CTGGGAGCACTGCGTCGCTCGTTACAAATTTTACCGGAACTTCGGGCCCTCTTAGGGGAG
GAAGTTGGGTTGCCAGATCTCTCACCTTTGAAGGAGGAATTGGAAGCTGCTCTGGTTGAG
GATCCTCCCCTCAAGGTTTCGGAAGGAGGCCTTATACGTGAGGGCTACGATCCTGATCTT
GATGCCCTGCGCGCGGCTCACCGTGAGGGTGTAGCGTACTTCCTGGAACTCGAAGAACGC
GAGCGGGAGCGGACTGGCATACCCACTTTGAAGGTCGGTTACAACGCTGTATTTGGTTAC
TACCTCGAAGTTACTCGGCCATACTATGAGCGTGTCCCGAAAGAATACCGCCCTGTACAA
ACACTTAAGGATCGCCAGCGCTATACGCTCCCAGAAATGAAGGAGAAAGAGCGGGAAGTT
63
60
120
180
240
300
360
420
480
540
600
660
720
780
840
900
960
1020
1080
1140
1200
1260
1320
1380
1440
1500
1501
1561
1621
1681
1741
1801
1861
1921
1981
2041
2101
2161
2221
2281
2341
2401
2461
TATCGGCTGGAAGCTCTCATCCGCCGTCGTGAGGAGGAGGTGTTCTTGGAGGTTCGTGAG
CGTGCTAAGCGGCAGGCCGAAGCTCTCCGTGAGGCGGCTCGGATACTCGCAGAACTTGAC
GTTTATGCGGCCCTGGCGGAGGTTGCGGTACGGTATGGATACGTACGCCCACGTTTCGGT
GATCGTCTTCAGATCCGTGCAGGGCGGCACCCAGTAGTCGAGCGTCGTACTGAATTCGTC
CCCAATGACCTGGAGATGGCGCATGAGCTGGTCCTTATTACAGGCCCGAACATGGCAGGT
AAGTCCACTTTCTTACGTCAGACAGCGTTGATCGCGCTTTTGGCGCAAGTAGGTTCTTTC
GTGCCTGCTGAGGAAGCGCACCTGCCGCTCTTCGATGGCATTTATACTCGTATAGGGGCC
TCGGATGATTTAGCTGGCGGAAAGTCAACATTTATGGTCGAGATGGAGGAAGTCGCCTTG
ATCCTGAAAGAAGCTACCGAGAACAGTCTCGTACTCCTTGATGAAGTCGGGCGCGGGACG
AGTTCACTCGACGGGGTAGCTATAGCCACTGCTGTTGCTGAGGCCCTTCACGAGCGCCGC
GCGTATACCTTGTTTGCCACACACTACTTCGAACTTACTGCGCTCGGATTACCGCGGTTG
AAAAATTTACACGTCGCCGCTCGCGAGGAAGCTGGGGGCCTGGTCTTTTATCACCAAGTT
CTGCCTGGACCAGCCTCTAAATCCTACGGAGTAGAAGTTGCTGCGATGGCCGGATTGCCC
AAGGAAGTCGTAGCACGTGCCCGTGCCCTGCTCCAGGCGATGGCGGCGCGGCGGGAAGGG
GCACTCGATGCAGTGTTGGAACGGTTGCTCGCGTTAGATCCCGACCGGCTGACTCCGCTG
GAAGCACTCCGGCTTCTGCAGGAATTAAAAGCCTTGGCGCTCGGGGCCCCCCTCGACACG
ATGAAGTGACTCGAGCGGAC
1560
1620
1680
1740
1800
1860
1920
1980
2040
2100
2160
2220
2280
2340
2400
2460
2480
Trna MutS protein sequence
1 MKVTPLHEQYLRIKEQYKDSILLFRLGDFYEAFFEDAKIVSKVLNIVLTRRQDAPMAGIP
61 YHALNTYLKKLVEAGYKVAICDQMEEPSKSKKLIRREVTRVVTPGSIVEDEFLSETNNYM
121 AVVSEEKGRYCTVFCDVSTGEVLVHESSDEQETLDLLKNYSISQIICPEHLKSSLKERFP
181 GVYTET==SEWYFSDLEEVEKAYNLKDIHHFELSPLALKALAALIKYVKYTMIAEDLNLKP
241 PLLISQEDYMILDSATVENLSLIPGDRGKNLFDVLNNTETPMGARLLKKWILHPLVDRKQ
301 IEERLK1~VERLVNDRVSLEEMRNLLSNVRDVERIVSRVEYNRSVPRDLVALRETLEIIPK
361 LNEVLS~~FGVFKKLAFPEGLVDLLRKAIEDDPVGSPGEGKVIKRGFSSELDEYRDLLEHA
421 EERLKEFEEKERERTGIQKLRVGYNQVFGYYIEVTKANLDKIPDDYERKQTLVNSERFIT
481 PELKEFETKIMAAKERIEELEKELFKSVCEEVKKHKEVLLEISEDLAKIDALSTLAYDAI
541 MYNYTKPVFSEDRLEIKGGRHPVVERFTQNFVENDIYMDNEKRFVVITGPNMSGKSTFIR
601 QVGLISLMAQIGSFVPAQKAILPVFDRIFTRMGARDDLAGGRSTFLVEMNEMALILLKST
661 NKSLVLLDEVGRGTSTQDGVSIAWAISEELIKRGCKVLFATHFTELTELEKHFPQVQNKT
721 ILVKEEGKNVIFTHKVVDGVADRSYGIEVAKIAGIPDRVINRAYEILERNFKNNTKKNGK
781 SNRFSQQIPLFPVX
Trna MutS Construct DNA sequence (with flanking sequences included)
1 CAGGGA1~TTCCATATGAAGGTAACCCCCCTTATGGAACAGTACCTGCGGATAAAAGAGCA
61 ATACAAGGATTCTATTCTTCTCTTTCGCCTCGGAGACTTTTATGAAGCCTTCTTCGAGGA
121 TGCGAAGATCGTCAGCAAAGTCCTTAACATTGTCTTAACTCGCCGTCAGGATGCTCCAAT
181 GGCTGGGATACCTTACCATGCACTTAATACCTACCTGAAAAAACTCGTGGAAGCGGGATA
241 CAAAGTGGCAATATGCGATCAGATGGAAGAGCCGAGCAAGTCCAAGAAGTTAATCCGTCG
301 TGAAGTPIACCCGCGTTGTGACGCCTGGCTCCATAGTAGAGGACGAGTTCTTATCGGAAAC
361 TAACAATTACATGGCGGTGGTTTCGGAAGAAAAGGGTCGCTACTGCACAGTGTTTTGCGA
421 CGTATC1'ACTGGTGAGGTTTTAGTTCATGAGTCTTCGGATGAGCAGGAGACGTTGGATCT
481 TCTCAAGAACTACAGTATTTCTCAGATTATCTGCCCGGAACACCTGAAGTCTAGTCTCAA
541 AGAGCGTTTCCCCGGAGTCTATACAGAGACAATCAGCGAATGGTACTTTAGTGATCTTGA
601 GGAAGTA.GAGAAGGCGTACAATCTTAAAGACATCCATCACTTCGAATTAAGCCCCTTAGC
661 CCTTAAA.GCCCTTGCCGCATTGATTAAGTACGTCAAATATACTATGATCGCCGAGGATCT
721 CAACTTA.AAACCGCCGTTGTTAATTAGCCAGCGTGACTATATGATATTGGACTCTGCAAC
781 CGTGGAGAACTTGAGTCTGATTCCAGGTGACCGGGGTAAAAATCTGTTTGATGTGCTTAA
841 TAACAC1GAAACACCTATGGGGGCTCGTTTGTTGAAGAAATGGATATTACATCCGCTGGT
901 AGACCGTAAACAAATAGAGGAGCGCCTCAAAGCAGTCGAACGCCTTGTGAATGATCGTGT
961 TTCGTTGGAGGAAATGCGTAATCTGCTCAGTAACGTTCGGGATGTTGAACGCATAGTAAG
1021 TCGTGTCGAGTACAACCGCAGCGTTCCACGGGATTTGGTCGCCCTTCGGGAAACCTTGGA
1081 AATCATTCCCAAGTTGAATGAGGTGCTTTCTACTTTTGGTGTATTCAAGAAACTCGCATT
1141 CCCGGAAGGTTTAGTAGATTTACTCCGGAAAGCAATTGAAGACGACCCCGTAGGGTCCCC
64
1201 TGGGGAGGGAAAGGTCATCAAGCGCGGATTTTCCAGTGAGCTCGATGAATACCGCGATCT
1261 CTTAGA1\CATGCCGAAGAACGGCTTAAGGAGTTTGAGGAGAAGGAACGCGAACGTACGGG
1321 CATACAGAAGCTGCGGGTGGGTTACAACCAGGTCTTTGGATACTACATTGAGGTGACAAA
1381 GGCCAACTTAGATAAGATACCGGACGACTACGAACGGAAGCAGACACTCGTGAACTCCGA
1441 GCGCTTCATCACGCCGGAGCTGAAAGAGTTCGAGACAAAAATCATGGCTGCCAAAGAACG
1501 TATCGAGGAGTTGGAGAAAGAACTGTTCAAATCAGTTTGTGAGGAGGTAAAGAAACACAA
1561 GGAGGTGTTGCTCGAAATCTCAGAGGACCTGGCAAAGATAGACGCCCTGTCAACACTTGC
1621 ATACGA~~GCAATCATGTACAACTACACTAAGCCGGTGTTTTCGGAGGATCGGCTGGAAAT
16 81 TAAGGG~~GGCCGGCATCCAGTCGTGGAGCGGTTTACCCAAAATTTCGTAGAAAACGACAT
1741 CTACATGGACAACGAGAAACGGTTCGTGGTTATTACTGGTCCAAACATGTCGGGTAAGTC
1801 TACGTTTATACGTCAGGTTGGGCTCATTAGCTTAATGGCACAAATTGGGTCTTTTGTACC
1861 AGCTCAGAAAGCGATTCTCCCCGTATTCGATCGGATCTTTACGCGCATGGGTGCCCGTGA
1921 CGATTTAGCTGGAGGTCGGTCAACTTTCCTCGTAGAGATGAACGAAATGGCCCTCATTTT
1981 GTTAAAATCCACGAATAAGTCGCTCGTGCTGTTAGACGAGGTAGGGCGTGGCACGTCTAC
2041 ACAAGACGGCGTCTCTATTGCGTGGGCCATCTCTGAGGAACTGATAAAGCGTGGATGCAA
2101 GGTCCTGTTCGCGACACATTTTACGGAGTTAACCGAGCTTGAAAAGCACTTCCCTCAAGT
2161 ACAGAACAAGACCATCTTGGTGAAGGAGGAGGGGAAGAATGTCATCTTCACTCATAAAGT
2221 CGTAGATGGAGTTGCCGACCGCTCTTATGGGATAGAGGTTGCTAAAATTGCAGGTATTCC
2281 AGACCGTGTTATCAATCGGGCCTACGAGATTTTGGAGCGCAATTTCAAAAACAATACCAA
2341 AAAGAATGGCAAGAGTAACCGCTTCTCACAGCAGATCCCACTTTTCCCGGTTTGACTCGA
2401 GCGGAC
Sequencing primers: Tma (2406 bp total, shoot for -500, 360, 860, 1360, 1860):
TmaMutSseql: GGTGTTCCGGGCAGATAATCTGAG (24 bases, 54%GC, Tm-58, 3' end @501)
TmaMutSseq2: CCATAGTAGAGGACGAGTTCTTATCG (26 bases, 46%GC, Tm-58, ends @355)
TmaMutSseq3: GAAGAAATGGATATTACATCCGCTGG (26 bases, 42%GC, Tm-56, ends @899)
TmaMutSseq4: GGGTGGGTTACAACCAGGTCTTTGG (25 bases, 56%GC, Tm-57, ends @1359)
TmaMutSseq5: ATGGCACAAATTGGGTCTTTTGTACC (26 bases, 42%GC, Tm-56, ends @1860)
Aae MutS protein sequence
1 MEKSEKELTPMLSQYHYFKNQYPDCLLLFRLGDFYELFYEDAYIGSKELGLVLTSRPAGK
61 GKERIPNCGVPYHSANSYIAKLVNKGYKVAICEQVEDPSKAKGIVKREVVRVITPGTFFE
121 RDTGGLASLYKKGNHYYVGYLNLAVGEFLGAKVKIEELLDLLSKLNIKEILVKKGEKLPE
181 ELEKVLKVYVSELEEEFFEEGSEEILKDFGVLSLQAFGFEEDTYSLPLGAVYKYAKTTQK
241 GYTPLIPRPKPYRDEGFVRLDIKAIKGLEILESLEGRKDISLFKVIDRTLTGMGRRRLKF
301 RLLSPFHSREKIERIQEGVQELKENREALLKIRQILEGMADLERLVSKISSNMATPRELV
361 YLKNSLKKVEELRLLLLELKAPIFKEILQNFEDTKKIINDIEKTLVEDPPLHVKEGGLIR
421 EGVNAYLDELRFIRDNAETYLREYEKKLRQETGIQSLKIGYNKVMGYYIEVTKPNLKYVP
481 SYFRRRC!TLSNSERFTTEELQRLEEKILSAQTRINDLEYELYKELRERVVKELDKVGNNA
541 SAVAEVDFIQSLAQIAYEKDWAKPQIHEGYELIIEEGRHPVIEEFVENYVPNDTKLDRDS
601 FIHVITGPNMAGKSSYIRQVGVLTLLSHIGSFIPARRAKIPVVDALFTRIGSGDVLALGV
661 STFMNE~[LEVSNILNNATEKSLVILDEVGRGTSTYDGIAISKAIVKYISEKLKAKTLLAT
721 HFLEITELEGKIEGVKNYHMEVEKTPEGIRFLYILKEGKAEGSFGIEVAKLAGLPEEVVE
781 EARKILRELEEKENKKEDIVPLLEETFKKSEEAQRLEEYEEIIKKIEEIDIGNTTPLQAL
841 LILAELKKKCSFSKKESGAX
Aae MutS Construct DNA sequence (with flanking sequences included)
1 CAGGGAATTCCATATGGAGAAGTCAGAAAAGGAATTAACCCCTATGTTAAGCCAATACCA
61 TTATTTCAAGAACCAGTACCCGGACTGTTTACTCTTGTTCCGGCTCGGGGATTTTTACGA
121 GTTGTTCTATGAAGATGCGTATATAGGGTCTAAAGAGCTCGGGTTGGTGCTGACATCCCG
181 CCCAGCGGGTAAGGGGAAAGAACGCATTCCCATGTGCGGAGTGCCATATCATTCTGCCAA
65
2 41 CTCCTAC11.TTGCGAAACTGGTAAACAAAGGATACAAAGTTGCTATTTGTGAGCAGGTCGA
301 GGATCCG1~CTAAGGCAAAGGGAATAGTAAAACGGGAGGTTGTACGGGTGATTACCCCGGG
361 AACCTTTTTCGAGCGCGACACAGGGGGGCTTGCTAGTCTCTATAAGAAAGGCAACCATTA
421 CTATGTGGGATATCTCAATCTCGCTGTAGGCGAATTCTTAGGAGCGAAAGTTAAGATTGA
481 GGAACTGCTTGACCTGCTTAGCAAACTCAATATCAAGGAAATCTTGGTTAAGAAGGGCGA
541 GAAACTTCCAGAGGAGCTGGAAAAGGTCCTGAAGGTGTACGTCAGCGAACTTGAGGAGGA
601 GTTTTTTGAGGAAGGTTCAGAAGAAATTCTCAAGGACTTCGGCGTTTTGTCGCTGCAAGC
661 ATTCGGGTTTGAAGAAGATACCTATAGCTTACCACTTGGTGCAGTCTACAAATACGCCAA
721 AACTACTCAGAAAGGGTACACGCCTTTGATACCACGCCCTAAACCATACCGCGATGAGGG
781 GTTCGTTCGCCTCGACATAAAAGCGATAAAGGGTCTCGAAATATTGGAGTCACTTGAAGG
841 CCGGAAGGACATTAGCCTGTTTAAGGTAATTGACCGTACGTTAACTGGGATGGGACGGCG
901 TCGTTTGPlAATTCCGTCTCTTATCGCCATTCCGCAGTCGGGAGAAAATAGAACGCATTCA
961 GGAAGGCGTACAGGAATTGAAAGAGAACCGCGAAGCCTTGCTGAAAATCCGTCAGATACT
1021 CGAAGGGPITGGCAGATCTCGAACGCCTCGTGTCGAAAATTTCGTCGAACATGGCGACTCC
1081 GCGCGAACTCGTTTATTTGAAAAATAGTTTAAAGAAGGTGGAAGAACTGCGGTTGTTGTT
1141 GCTTGAGTTAAAGGCGCCGATATTCAAGGAGATACTGCAGAACTTCGAGGACACGAAGAA
1201 AATTATCP.ATGACATCGAGAAGACTTTGGTAGAGGATCCACCGTTACATGTTAAAGAGGG
1261 GGGGTTGP.TACGTGAGGGGGTGAATGCATATCTTGATGAGCTTCGTTTTATTCGGGACAA
1321 CGCGGAGP.CC TATTTACGTGAATACGAAAAGAAGCTGCGCCAAGAGACTGGCATCCAGAG
~381 CTTGAAGP.TAGGATATAACAAGGTCATGGGTTACTATATCGAGGTGACGAAACCAAACTT
:441 AAAGTACGTTCCATCTTACTTCCGCCGTCGTCAGACTCTTAGTAATAGCGAACGGTTCAC
1501 TACAGAGGAACTTCAGCGCCTGGAGGAAAAGATTCTGAGCGCCCAGACACGGATTAACGA
1561 TCTTGAGTATGAACTTTACAAGGAGTTACGCGAGCGGGTCGTCAAAGAGTTGGACAAGGT
1621 AGGGAAC1\ACGCTTCGGCCGTTGCCGAGGTCGACTTTATACAATCTCTCGCTCAAATTGC
1681 TTATGAM.AAGACTGGGCAAAACCCCAGATCCATGAGGGCTACGAGCTTATAATCGAGGA
1741 GGGACGTCATCCTGTGATCGAGGAATTTGTTGAAAACTATGTCCCCAACGATACGAAGTT
180 1 AGACCGTG:ACTCGTTCATCCATGTTATTACCGGACCCAATATGGCCGGTAAGTCTAGTTA
1861 TATTCGGCAAGTCGGCGTTTTGACTTTGCTCAGCCACATTGGATCTTTTATACCTGCACG
1921 TCGGGCGA.AGATCCCTGTCGTAGACGCTCTCTTTACGCGGATTGGTTCAGGCGACGTTTT
1981 AGCTTTAGGCGTTTCTACATTTATGAATGAGATGCTGGAGGTGTCTAACATCCTTAACAA
2041 TGCGACGGAAAAGTCGCTCGTGATCCTGGACGAAGTGGGTCGTGGTACAAGCACTTATGA
2101 TGGAATCGCAATTAGTAAGGCTATCGTGAAATACATATCCGAAAAGCTGAAAGCCAAGAC
2161 TCTGTTGGCAACCCATTTCTTAGAGATCACCGAATTAGAGGGGAAGATCGAGGGAGTCAA
~~ 221 GAACTATC.ACATGGAAGTCGAGAAAACACCTGAGGGTATTCGCTTTCTGTATATTCTGAA
22 81 GGAGGGCA.AAGCCGAAGGCTCGTTTGGCATAGAAGTAGCAAAATTAGCTGGCCTGCCGGA
2341 GGAGGTGGTCGAAGAAGCACGTAAGATCCTCCGCGAGTTAGAGGAGAAAGAAAACAAGAA
2401 AGAGGACA.rCGTGCCATTGTTGGAAGAGACATTCAAAAAGTCCGAGGAAGCCCAACGTTT
2461 GGAGGAGT.ACGAGGAAATAATCAAAAAAATCGAAGAGATCGACATCGGGAATACCACTCC
2521 CTTGCAGGCTCTGCTCATACTTGCGGAACTTAAGAAAAAATGTTCATTCTCCAAGAAGGA
2581 ATCCGGTGCCTGACTCGAGCGGAC
Sequencing primers
Aae (2604 bp total, shoot for -580, 440, 970, 1500, 2030):
AaeMutSseq1: 'rCCTCAAGTTCGCTGACGTACACC (24 bases, 54%GC, Tm-59, 3' ends @574)
AaeMutSseq2: AGGCAACCATTACTATGTGGGATATCTC (28 bases, 43%GC, Tm-58, ends @436)
AaeMutSseq3: GGAAGGCGTACAGGAATTGAAAGAG (25 bases, 48%GC, Tm-58, ends @985)
AaeMutSseq4: CGTCGTCAGACTCTTAGTAATAGCG (25 bases, 48%GC, Tm-59, ends @1490)
AaeMutSseq5: GAATGAGATGCTGGAGGTGTCTAAC (25 bases, 48%GC, Tm-57, ends @2029)
EGFP sequence:
GGGGACCACTTTGTACAAGAAAGCTGGGTCGCAACGCAATTAATGTGAGTTAGCTCACTCATTAGGCACCCCAGGCT
TTACACTTTATGCTTCCGGCTCGTATGTTGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTATGA
CCATGATTACGCCTAGCTTGCATGCCTGCAGGTCGACTCTAGAGGATCCCCGGGTACCGGTCGCCACCATGGTGAGC
AAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAG
CGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGC
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CCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAG
CAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAA
CTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCA
AGGAGGACGGCA1~CATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAG
CAGAAGAACGGC1~,TCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTA
CCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGA
GCAAAGACCCCA1~CGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATG
GACGAGCTGTAC1~GTAAAGCGGCCGCGACTCTAGAATTCAGCCTGCTTTTTTGTACAAACTTGTGGGG
EGFP oligos: ()peron 2nd set, parsed with DNAWorks 3.0 (including flanking sequences for
Clonase (Invitrogen))
EGFP-N50tl GGGGACCACTTTGTACAAGAAAGCTGGGT
EGFP-N50b2 ACTCACATTAATTGCGTTGCGACCCAGCTTTCTTGTACAAAG
EGFP-N50t3 GCAACGCAATTAATGTGAGTTAGCTCACTCATTAGGCACCCC
EGFP-N50b4 CGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAG
EGFP-N50t5 GGCTTTACACTTTATGCTTCCGGCTCGTATGTTGTGTGGAAT
EGFP-N50b6 GTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGC
EGFP-N50t7 TGTGAGCGGATAACAATTTCACACAGGAAACAGCTATGACCA
EGFP-N50b8 GCATGCAAGCTAGGCGTAATCATGGTCATAGCTGTTTCCTGT
EGFP-N50t9 ACGCCTAGCTTGCATGCCTGCAGGTCGACTCTAGAGGATCCC
EGFP-N50bl0 CCATGGTGGCGACCGGTACCCGGGGATCCTCTAGAGTCGACC
EGFP-N50tll CCGGTCGCCACCATGGTGAGCAAGGGCGAGGAGCTGTTCACC
EGFP-N50b12 GCTCGACCAGGATGGGCACCACCCCGGTGAACAGCTCCTCGC
EGFP-N50t13 CCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAG
EGFP-N50b14 CTCGCCCTCGCCGGACACGCTGAACTTGTGGCCGTTTACGTC
EGFP-N50t15 CCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCC
EGFP-N50b16 TGCCGGTGGTGCAGATGAACTTCAGGGTCAGCTTGCCGTAGG
EGFP-N50t17 ATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTC
-
EGFP-N50b18 CTGCACGCCGTAGGTCAGGGTGGTCACGAGGGTGGGCCAGGG
EGFP-N50t19 GACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACAT
EGFP-N50b20 GGACTTGAAGAAGTCGTGCTGCTTCATGTGGTCGGGGTAGCG
EGFP-N50t21 AGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCC
EGFP-N50b22 GTCCTTGAAGAAGATGGTGCGCTCCTGGACGTAGCCTTCGGG
EGFP-N50t23 GCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCG
EGFP-N50b24 TGTCGCCCTCGAACTTCACCTCGGCGCGGGTCTTGTAGTTGC
EGFP-N50t25 TGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGA
EGFP-N50b26 CGTCCTCCTTGAAGTCGATGCCCTTCAGCTCGATGCGGTTCA
EGFP-N50t27 CATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCT
EGFP-N50b28 GTTGTGGCTGTTGTAGTTGTACTCCAGCTTGTGCCCCAGGAT
EGFP-N50t29 TACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAG
EGFP-N50b30 CACCTTGATGCCGTTCTTCTGCTTGTCGGCCATGATATAGAC
EGFP-N50t31 GAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACAT
EGFP-N50b32 CGAGCTGCACGCTGCCGTCCTCGATGTTGTGGCGGATCTTGA
EGFP-N50t33 GCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCA
EGFP-N50b34 GGCAGCAGCACGGGGCCGTCGCCGATGGGGGTGTTCTGCTGG
EGFP-N50t35 CCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTC
67
EGFP-N50b36
EGFP-N50t37
EGFP-N50b38
EGFP-N50t39
EGFP-N50b40
EGFP-N50t41
EGFP-N50b42
CGTTGGGGTCTTTGCTCAGGGCGGACTGGGTGCTCAGGTAGT
TGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGC
TCCCGGCGGCGGTCACGAACTCCAGCAGGACCATGTGATCGC
ACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAG
TTCTAGAGTCGCGGCCGCTTTACTTGTACAGCTCGTCCATGC
CGGCCGCGACTCTAGAATTCAGCCTGCTTTTTTGTACAAACT
CCCCACAAGTTTGTACAAAAAAGCAGGCT
GFP Sequencing primers
GFP-F: CCTCGTGACCACCCTGAC (faces forward, internal to sequence)
GFP-R: CACCAGGGTGTCGCCCTC (faces backward, internal to sequence)
68
